Compositions comprising insoluble alpha-glucan

By using a composition of water-insoluble α-glucan with crosslinking agents or additives, and removing some additives through specific treatment methods, the problem of insufficient performance and economic value of existing insoluble α-glucan materials is solved, and the problem of insufficient performance and economic value of existing insoluble α-glucan materials is achieved. Performance improvement and application breadth expansion.

CN118900882APending Publication Date: 2024-11-05NUTRITION & BIOSCIENCES USA 4 INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202380029072.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2022-04-26
Filing Date
2023-03-21
Publication Date
2024-11-05

AI Technical Summary

Technical Problem

Existing insoluble α-glucan materials have insufficient performance and economic value in a variety of applications, and new forms need to be developed to improve their performance characteristics.

Method used

Using a composition containing water-insoluble α-glucan and a crosslinking agent or additive, the fiber strips are contacted with a non-caustic aqueous liquid by a specific treatment method to remove some of the additives to form a material with improved performance.

Benefits of technology

It improves the performance characteristics and economic value of the material, realizes easier preparation of insoluble α-glucan fibers and films, and enhances its applicability in different applications.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118900882A_ABST
    Figure CN118900882A_ABST
Patent Text Reader

Abstract

Disclosed herein are compositions, such as fibrils, comprising at least a water-insoluble alpha-glucan and an additive. At least about 50% of the glycosidic bonds of the alpha-glucan may be alpha-1, 3 glycosidic bonds. The additive is typically not chemically linked to the alpha-glucan. Further disclosed are methods for preparing and treating these compositions.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] This application claims the benefit of U.S. Provisional Application Nos. 63 / 321,840 (filed on March 21, 2022), 63 / 321,831 (filed on March 21, 2022), and 63 / 334,893 (filed on April 26, 2022), each of which is incorporated herein by reference in its entirety. Technical Field

[0002] The present disclosure belongs to the field of polysaccharides. For example, the present disclosure relates to a composition comprising insoluble α-glucan and at least one cross-linking agent and / or additive and the use of the material in various applications. Background Art

[0003] Driven by the desire to use polysaccharides in various applications, researchers have explored biodegradable and economically manufactured polysaccharides from raw materials from renewable sources. One such polysaccharide is α-1,3-glucan, which is an insoluble glucan polymer characterized by having α-1,3-glycosidic bonds. For example, this polymer has been prepared using glucosyltransferases isolated from Streptococcus salivarius (Simpson et al., Microbiology [Microbiology] 141: 1451-1460, 1995). For example, U.S. Patent No. 7000000 discloses the preparation of spun fibers by enzymatically produced α-1,3-glucans. A variety of other glucan materials have also been studied for the development of new applications or enhanced applications. For example, U.S. Patent Application Publication No. 2015 / 0232819 discloses the enzymatic synthesis of several insoluble glucans with mixed α-1,3 and α-1,6 bonds.

[0004] New forms of insoluble α-glucan are needed to improve the economic value and performance characteristics of this material in various applications. To meet this need, compositions comprising insoluble α-glucan and one or more crosslinking agents and / or additives are described herein. Summary of the invention

[0005] In one embodiment, the present disclosure relates to a composition comprising fibrids (hybrid fibrids), which contain water-insoluble α-glucan and an additive, wherein (i) at least about 50% of the glycosidic bonds of the α-glucan are α-1,3 glycosidic bonds and the weight-average degree of polymerization of the α-glucan is at least 15, and (ii) the additive is not chemically linked to the α-glucan.

[0006] In another embodiment, the present disclosure is directed to a method for treating fibrids (hybrid fibrids). This method may include: (a) providing the fibrids herein, and (b) contacting the fibrids with a non-caustic aqueous liquid, wherein the contacting does not remove any additives from the fibrids, or the contacting removes less than 20 wt% of the additives from the fibrids. BRIEF DESCRIPTION OF THE DRAWINGS

[0007] Figure 1A : A continuous α-1,3-glucan dope filament is drawn by air through a melt-blowing die using an α-1,3-glucan dope solution containing a cross-linking agent.

[0008] Figure 1B : Shows a failed attempt to air-draw α-1,3-glucan stock solution filaments through a melt-blowing die using an α-1,3-glucan stock solution without a cross-linking agent.

[0009] Figure 2 : α-1,3-glucan films with 5 wt%, 10 wt%, 15 wt% or 20 wt% (relative to the content of α-1,3-glucan in the film) of paraffin additive are shown. The films are shown on the left side of each image (the right side is not covered by the film). Reference Example 7C.

[0010] Figure 3 : Alpha-1,3-glucan films with 10 wt%, 15 wt% or 20 wt% (relative to the content of alpha-1,3-glucan in the film) rapeseed oil additive are shown. A water droplet is placed on the inside or outside of the film (the inside of the 20 wt% rapeseed oil film is not shown). The contact angle of water on the inside of each film is less than the contact angle of water on the outside of each film. Reference Example 7D. DETAILED DESCRIPTION

[0011] The disclosures of all cited patent and non-patent literature are incorporated herein by reference in their entirety.

[0012] Unless disclosed otherwise, the terms "a" or "an" as used herein are intended to cover one or more (ie, at least one) of the referenced features.

[0013] If present, unless otherwise indicated, all ranges are inclusive and combinable. For example, when a range of "1 to 5" (i.e., 1-5) is listed, the listed range should be interpreted as including ranges "1 to 4", "1 to 3", "1-2", "1-2 and 4-5", "1-3 and 5", etc. Unless otherwise clearly indicated, the numerical values ​​of various ranges in this disclosure are stated as approximate values, as if the minimum and maximum values ​​in the stated ranges are preceded by the word "about". In this way, slight variations above and below the described ranges can typically be used to achieve results substantially the same as the values ​​within these ranges. In addition, the disclosure of these ranges is intended to be a continuous range of every value between the minimum and maximum values.

[0014] Each maximum numerical limit given throughout this specification is intended to include each lower numerical limit, as if such lower numerical limits were expressly written herein. Each minimum numerical limit given throughout this specification will include each higher numerical limit, as if such higher numerical limits were expressly written herein. Each numerical range given throughout this specification will include each narrower numerical range falling within such wider numerical range, as if such narrower numerical ranges were all expressly written herein.

[0015] It should be understood that, for clarity, certain features of the present disclosure described above and below in the context of aspects / embodiments may also be provided in combination in a single element. Conversely, for brevity, various features of the present disclosure described in the context of a single aspect / embodiment may also be provided separately or in any sub-combination.

[0016] The term "polysaccharide" (or "glycan") means a polymeric carbohydrate molecule composed of long chains of monosaccharide units bound together by glycosidic bonds and which, when hydrolyzed, yields the constituent monosaccharides and / or oligosaccharides of the polysaccharide. The polysaccharide herein may be linear or branched, and / or may be a homopolysaccharide (composed of only one type of constituent monosaccharide) or a heteropolysaccharide (composed of two or more different constituent monosaccharides). Examples of polysaccharides herein include glucans (polyglucose), fructans (polyfructans), galactans (polygalactans), mannans (polymannans), arabinans (polyarabinans), xylans (polyxyloses), and soy polysaccharides.

[0017] Unless otherwise indicated, the term "sugar" and other similar terms refer to monosaccharides and / or disaccharides / oligosaccharides in this article. "Disaccharides" herein refer to carbohydrates with two monosaccharides connected by glycosidic bonds. "Oligosaccharides" herein may refer to carbohydrates with 3 to 15 monosaccharides, for example, connected by glycosidic bonds. Oligosaccharides may also be referred to as "oligomers". The monosaccharides (e.g., glucose and / or fructose) contained in disaccharides / oligosaccharides may be referred to as "monomer units", "monosaccharide units" or other similar terms.

[0018] " Glucan " herein is a class of polysaccharides, which are polymers (polyglucose) of glucose. Glucan can be made up of, for example, about or at least about 90 wt %, 91 wt %, 92 wt %, 93 wt %, 94 wt %, 95 wt %, 96 wt %, 97 wt %, 98 wt %, 99 wt % or 100 wt % glucose monomer units. The example of Glucan herein includes alpha-glucan.

[0019] The terms "α-glucan", "α-glucan polymer", etc. are used interchangeably herein. α-glucan is a polymer comprising glucose monomer units linked together by α-glycosidic bonds. In typical aspects, the glycosidic bonds of the α-glucans herein are about, or at least about 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, or 100% α-glycosidic bonds. Examples of α-glucan polymers herein include α-1,3-glucan.

[0020] The terms "α-1,3-glucan", "poly α-1,3-glucan", "α-1,3-glucan polymer", etc. are used interchangeably herein. α-1,3-glucan is an α-glucan comprising glucose monomer units linked together by glycosidic bonds, wherein at least about 50% of the glycosidic bonds are α-1,3. In some aspects, the α-1,3-glucan comprises about, or at least about 90%, 95%, or 100% α-1,3 glycosidic bonds. Most or all of the other bonds (if present) in the α-1,3-glucan herein are typically α-1,6, although some bonds may also be α-1,2 and / or α-1,4. The α-1,3-glucan herein is typically water-insoluble.

[0021] In some aspects herein, the terms "dextran," "dextran polymer," "dextran molecule," "α-1,6-glucan," and the like refer to a water-soluble α-glucan comprising at least 50%, 60%, 70%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, 99%, or 99.5% α-1,6 glycosidic bonds (the remainder of the bonds are typically all or mostly α-1,3).

[0022] The term "copolymer" herein refers to a polymer comprising at least two different types of α-glucans (such as dextran and α-1,3-glucan). The terms "graft copolymer", "branched copolymer", etc. herein generally refer to a copolymer comprising a "backbone" (or "main chain") and one or more side chains branching from the backbone. One or more side chains are structurally different from the backbone. Examples of graft copolymers herein include a dextran backbone (or, for example, a dextran backbone modified with about 1%-35% of α-1,2 and / or α-1,3 branches) and at least one α-1,3-glucan side chain comprising at least about 50% α-1,3 glycosidic bonds. For example, the α-1,3-glucan side chain herein may have the bonds and molecular weight of α-1,3-glucans as disclosed herein. In some aspects, the dextran backbone can have α-1,3-glucan extensions, as one or more non-reducing ends of the dextran can initiate α-1,3-glucan synthesis by glucosyltransferases.

[0023] The terms "linkage", "glycosidic linkage", "glycosidic bond" and the like refer to covalent bonds linking sugar monomers within a carbohydrate compound (oligosaccharide and / or polysaccharide). Examples of glycosidic bonds include 1,6-α-D-glycosidic bonds (also referred to herein as "α-1,6" bonds) and 1,3-α-D-glycosidic bonds (also referred to herein as "α-1,3" bonds).

[0024] The glycosidic bond profile of a polysaccharide or its derivatives can be determined using any method known in the art. For example, the glycosidic bond profile can be determined using nuclear magnetic resonance (NMR) spectroscopy (e.g., 13 C NMR and / or 1 H NMR) to determine the bond spectrum. These and other methods that can be used are disclosed in, for example, FoodCarbohydrates:Chemistry, PhysicalProperties,andApplications [ Food Carbohydrates: Chemistry, Physical Properties and Applications] (SW Cui ed., Chapter 3, SW Cui, Structural Analysis of Polysaccharides, Taylor & Francis Group LLC, Boca Raton, Florida, 2005), which is incorporated herein by reference.

[0025] As referred to herein, "α-1,2 branches" (and similar terms) typically contain glucose α-1,2-linked to the dextran backbone; therefore, the α-1,2 branches herein may also be referred to as α-1,2,6 bonds. The α-1,2 branches herein typically have one glucose group (which may alternatively be referred to as a side chain glucose).

[0026] As referred to herein, "α-1,3 branches" (and similar terms) typically contain glucose α-1,3-linked to the dextran backbone; therefore, the α-1,3 branches herein may also be referred to as α-1,3,6 bonds. The α-1,3 branches herein typically have one glucose group (which may alternatively be referred to as a side chain glucose).

[0027] The percentage of branches in the polysaccharide herein refers to the percentage of all bonds in the polysaccharide that represent branch points. For example, the percentage of α-1,3 branches in the α-glucan herein refers to the percentage of all bonds in the glucan that represent α-1,3 branch points. Unless otherwise specified, the percentage of bonds disclosed herein is based on the total bonds of the polysaccharide, or for the portion of the polysaccharide to which the disclosure specifically relates.

[0028] The "molecular weight" of a polysaccharide or polysaccharide derivative herein can be expressed as a weight average molecular weight (Mw) or a number average molecular weight (Mn), and its unit is Dalton (Da) or grams per mole. Alternatively, the molecular weight can be expressed as DPw (weight average degree of polymerization) or DPn (number average degree of polymerization). The molecular weight of a smaller polysaccharide polymer (such as an oligosaccharide) can be optionally provided as "DP" (degree of polymerization), and DP refers only to the number of monomers contained in the polysaccharide; "DP" can also characterize the molecular weight of a polymer based on a single molecule. Various means for calculating these different molecular weight measurements are known in the art, such as using high pressure liquid chromatography (HPLC), size exclusion chromatography (SEC), or gel permeation chromatography (GPC).

[0029] As used herein, Mw = ΣNiMi 2 / ΣNiMi calculates Mw; wherein Mi is the molecular weight of a single chain i and Ni is the number of chains having that molecular weight. In addition to SEC, the Mw of a polymer can be determined by other techniques such as static light scattering, mass spectrometry, MALDI-TOF (matrix-assisted laser desorption / ionization time of flight), small-angle X-ray or neutron scattering, or ultracentrifugation. As used herein, Mn can be calculated as Mn=ΣNiMi / ΣNi, wherein Mi is the molecular weight of chain i and Ni is the number of chains having that molecular weight. In addition to SEC, the Mn of a polymer can be determined by various colligative methods such as vapor pressure osmosis, by spectroscopy such as proton NMR, proton FTIR, or end group determination by UV-Vis. As used herein, DPn and DPw can be calculated from Mw and Mn, respectively, by dividing them by the molar mass M1 of one monomer unit. In the case of an unsubstituted dextran polymer, M1=162. In the case of a substituted (derivatized) dextran polymer, M1=162+M f x DoS, where M f is the molar mass of the substituent group, and DoS is the degree of substitution (average number of substituent groups per one glucose unit of the dextran polymer).

[0030] The "cake" of insoluble alpha-glucan herein refers to a preparation in concentrated, compacted, packaged, extruded and / or compressed form, which contains at least (i) about 50% by weight to 90% by weight of water or an aqueous solution, and (ii) about 10% by weight to 50% by weight of insoluble alpha-glucan. In some aspects, the cake of insoluble alpha-glucan herein may contain at least (i) about 20% by weight to 90% by weight of water or an aqueous solution, and (ii) about 10% by weight to 80% by weight of insoluble alpha-glucan. In some aspects, the cake may be referred to as a "filter cake" or a "wet cake". The cake herein typically has a soft, solid consistency.

[0031] The compositions herein (which are "dry" or "dried") typically have less than about 12 wt%, 11 wt%, 10 wt%, 9 wt%, 8 wt%, 7 wt%, 6 wt%, 5 wt%, 4 wt%, 3 wt%, 2 wt%, 1 wt%, 0.5 wt%, or 0.1 wt% water contained therein.

[0032] As used herein, the term "aqueous liquid", "aqueous fluid", "aqueous conditions", "aqueous reaction conditions", "aqueous environment", "aqueous system", etc. may refer to water or an aqueous solution. "Aqueous solution" herein may include one or more dissolved salts, wherein the maximum total salt concentration may be about 3.5wt% in some aspects. Although the aqueous liquid herein typically includes water as the only solvent in the liquid, the aqueous liquid may optionally include one or more other solvents (e.g., polar organic solvents) that are miscible in water. Therefore, the aqueous solution may include a solvent having at least about 10wt% water.

[0033] "Aqueous composition" herein has a liquid component comprising, for example, about, or at least about 10, 20, 30, 40, 50, 60, 70, 80, 90, 95, 99, or 100 wt % water. Examples of aqueous compositions include, for example, some mixtures, solutions, dispersions (e.g., colloidal dispersions), suspensions, and emulsions.

[0034] As used herein, the term "colloidal dispersion" refers to a heterogeneous system having a dispersed phase and a dispersion medium, that is, microscopically dispersed insoluble particles are suspended throughout another substance (e.g., an aqueous composition, such as water or an aqueous solution). An example of a colloidal dispersion herein is a hydrocolloid. All or a portion of the particles of a colloidal dispersion (such as a hydrocolloid) may contain insoluble α-glucan as disclosed in the present invention. The terms "dispersant" and "dispersion agent" are used interchangeably herein and refer to materials that promote the formation and / or stability of a dispersion. "Dispersion" herein refers to the action of preparing a dispersion of a material in an aqueous liquid.

[0035] The "insoluble", "aqueous-insoluble", "water-insoluble" (and similar terms) α-glucan or derivative thereof (e.g., α-1,3-glucan having a DP of 8 or more) herein does not dissolve (or does not appreciably dissolve) in water or other aqueous conditions, optionally wherein the aqueous conditions are further characterized by having a pH of 4-9 or 4-9.9 (e.g., pH 6-8) (i.e., non-harsh aqueous conditions) and / or a temperature of about 1°C to 130°C (e.g., 20°C-25°C). In some aspects, less than 1.0 gram (e.g., undetectable amount) of the aqueous-insoluble α-glucan herein dissolves in 1000 milliliters of such aqueous conditions (e.g., water at 23°C). In contrast, "soluble," "water-soluble," "water-soluble" glucans herein, such as certain oligosaccharides, etc. (e.g., α-1,3-glucans having a DP of less than 8) are clearly soluble under these conditions. Water-insoluble α-glucans or derivatives thereof herein are typically soluble in harsh aqueous conditions (e.g., aqueous solutions having a pH ≥ 11, 10.5, or 10.0, optionally having a temperature of about 1°C to 130°C [e.g., 20°C-25°C]).

[0036] As used herein, the term "viscosity" refers to a measure of the degree to which a fluid (aqueous or non-aqueous) resists forces tending to cause it to flow. Various viscosity units that may be used herein include, for example, centipoise (cP, cps) and Pascal-seconds (Pa·s). One centipoise is one hundredth of a poise; one poise is equal to 0.100 kg·m -1 ·s -1 . In some aspects, viscosity can be reported as "intrinsic viscosity" (IV, η, in dL / g); the term refers to a measure of the contribution of a glucan polymer to the viscosity of a liquid (e.g., a solution) containing the glucan polymer. IV measurements herein can be obtained, for example, using any suitable method, such as disclosed in U.S. Patent Application Publication Nos. 2017 / 0002335, 2017 / 0002336, or 2018 / 0340199, or Weaver et al. (J. Appl. Polym. Sci. [Journal of Applied Polymer Science] 35: 1631-1637) or Chun and Park (Macromol. Chem. Phys. [Polymer Chemistry and Physics] 195: 701-711), all of which are incorporated herein by reference. For example, IV can be measured in part by dissolving the dextran polymer (optionally at about 100° C. for at least 2, 4, or 8 hours) in DMSO with about 0.9 wt % to 2.5 wt % (e.g., 1 wt %, 2 wt %, 1-2 wt %) LiCl. IV herein can optionally be used as a relative measure of molecular weight.

[0037] The terms "contact angle," "wetting angle," and similar terms herein refer to the angle formed when a drop of water or an aqueous solution is placed on a material surface and the drop forms a dome shape on the surface. The angle formed between the material surface and a line tangent to the edge of the drop is the contact angle. For example, as the water drop spreads on the material surface and the dome of the drop becomes flatter, the contact angle becomes smaller. If the water drop forms a bead on the material surface (e.g., when there is high surface tension), the dome of the drop is higher and the contact angle becomes larger.

[0038] As used herein, the term "zeta potential" refers to the potential difference between a dispersion medium and a fluid fixed layer attached to particles dispersed in the dispersion medium. Typically, dispersed particles with a high zeta potential (negative or positive) have higher electrical stability than dispersed materials with a low zeta potential (close to zero). Since the repulsive force of high zeta potential materials in the dispersion tends to exceed its attractive force, such dispersions are relatively more stable than dispersions of low zeta potential materials, which tend to be more prone to flocculation / coagulation. The zeta potential herein can be measured as disclosed in, for example, U.S. Patent No. 6109098 or 4602989, U.S. Patent Application Publication No. 2020 / 0131281, or International Patent Application Publication No. WO2014 / 097402 or EP0869357, which are incorporated herein by reference.

[0039] The terms "crosslink", "crosslinked", etc. herein refer to one or more bonds (typically covalent bonds) connecting polymers such as insoluble α-glucan or derivatives thereof as disclosed in the present invention. Crosslinks with multiple bonds typically contain one or more atoms that are part of a crosslinking agent used to form the crosslinks. The terms "crosslinking agent", "crosslinker", etc. herein refer to atoms or compounds that can produce crosslinks. The terms "crosslinking reaction" and similar terms (e.g., "crosslinking composition", "crosslinking formulation") herein typically refer to a reaction comprising at least a solvent, a crosslinking agent and a water-insoluble α-glucan or derivative thereof and optionally a non-crosslinking agent additive; the crosslinking reaction herein can be maintained under the harsh conditions herein or under non-harsh conditions herein.

[0040] "Stock solution", "stock solution", "caustic solution", "basic solution", "alkaline solution" and the like herein refer to a solution (typically an aqueous solution having a pH ≥ 11) in which one or more of water-insoluble α-glucan, its water-insoluble derivative, and / or water-insoluble cross-linked α-glucan (e.g., all insoluble in aqueous solutions of pH 4-9) are dissolved. The additives herein may or may not be soluble in the caustic solution herein.

[0041] " stock solution filament" (and similar terms) herein refers to the filament of stock solution solution. Typically, stock solution filament is formed by making the stock solution solution herein be transmitted through a hole or nozzle (such as from a spinneret, a die head or other devices that can be used to form stock solution filament). For example, the stock solution filament can be exposed to acid to solidify one or more of its dissolved components into fiber filaments. As another example, the stock solution filament can be air-blown to remove liquid, thereby forming the fiber filament of one or more of its previously dissolved components.

[0042] "Polysaccharide derivatives" (and similar terms) herein (e.g., glucan derivatives such as α- or β-glucan derivatives) typically refer to polysaccharides that have been substituted with at least one type of organic group. The degree of substitution (DoS) of the polysaccharide derivatives herein can be up to about 3.0 (e.g., from about 0.001 to about 3.0). For example, the organic group can be attached to the polysaccharide derivatives herein via an ether, ester, carbamate / carbamoyl, or sulfonyl bond. The precursor of the polysaccharide derivative herein refers to the underivatized polysaccharide used to prepare the derivative (which can also be referred to as the polysaccharide portion of the derivative). For example, the organic group herein can be uncharged (neutral) or charged (anionic or cationic); generally, such a charge can be the charge that the organic group would have when it is in the aqueous composition herein, taking into account the pH of the aqueous composition (in some aspects, the pH can be 4-10 or 5-9, or any pH as disclosed herein).

[0043] The term "degree of substitution" (DoS, or DS) as used herein refers to the average number of hydroxyl groups substituted by organic groups (e.g., via ether, ester, or other bonds herein) in each monomer unit of a polysaccharide derivative. The DoS of a polysaccharide derivative herein may be stated with reference to the DoS of a particular substituent or to the overall DoS, which is the sum of the DoS values ​​of different substituent types (e.g., if it is a mixed ether or mixed ester). Unless otherwise disclosed, when the DoS is stated without reference to a particular substituent type, the total DoS is meant. In some aspects herein, the DoS (such as for a mixed solid composition) may be optionally characterized as an "effective DoS", where the DoS measurement is performed on polysaccharide samples of two or more populations having the same polysaccharide (e.g., the same molecular weight and bond spectrum), but where each polysaccharide population has a different DoS achieved with the same organic group. For example, the effective DoS of a hybrid solid composition herein having a certain amount of ether-derivatized α-glucan (e.g., having a DoS of one specific organic group of 0.001 to 3.0) and a certain amount of underivatized α-glucan (DoS 0.0) can be measured. In some aspects, any DoS value / range disclosed herein can be the effective DoS.

[0044] The terms used herein for "ether" (e.g., polysaccharide ether derivatives) may be as disclosed in, for example, U.S. Patent Application Publication Nos. 2014 / 179913, 2016 / 0304629, 2016 / 0311935, 2015 / 0239995, 2018 / 0230241, 2018 / 0237816, or 2020 / 0002646, or International Patent Application Publication Nos. WO2021 / 252569, WO2021 / 247810, or WO2021257786, or U.S. Patent Application No. 63 / 276,163, each of which is incorporated herein by reference. The terms "polysaccharide ether derivatives," "polysaccharide ether compounds," "polysaccharide ethers," etc. are used interchangeably herein. The polysaccharide ether derivatives herein are polysaccharides that have been etherified with one or more organic groups such that the derivatives have a DoS achieved with one or more organic groups of up to about 3.0 (e.g., about 0.001 to about 3.0). G -OC- is called "ether", where "-C G "-" represents a carbon atom of a monomer unit of a polysaccharide ether derivative (e.g., glucose) (wherein such a carbon atom is bonded to a hydroxyl group [-OH] in a polysaccharide precursor of the ether), and wherein "-C-" is a carbon atom of an organic group. Examples of polysaccharide ethers herein include glucan ethers (e.g., α- or β-glucan ethers).

[0045] In some aspects, the organic group may refer to (i) an H 2n+1 The term "alkyl" refers to a chain of carbon atoms that is (i.e., a fully saturated alkyl group) or (ii) is mostly saturated but has one or more carbons that have been replaced with one or more hydrogen atoms or functional groups (i.e., a "substituted alkyl group"). Such substitution may be with one or more hydroxyl groups, oxygen atoms (thereby forming an aldehyde or keto group), carboxyl groups, or other alkyl groups. Thus, as examples, an organic group herein may be an alkyl group, a carboxyalkyl group, or a hydroxyalkyl group.

[0046] A "carboxyalkyl" group herein refers to a substituted alkyl group in which one or more hydrogen atoms of the alkyl group are replaced by a carboxyl group. A "hydroxyalkyl" group herein refers to a substituted alkyl group in which one or more hydrogen atoms of the alkyl group are replaced by a hydroxyl group. Carboxyalkyl groups (e.g., carboxymethyl) are typically anionic under aqueous conditions.

[0047] Organic group can refer to "positively charged organic group". As used herein, positively charged organic group refers to a chain of one or more carbons having one or more hydrogens (i.e., "substituted alkyl") replaced by another atom or functional group, wherein one or more of these substitutions are with positively charged groups. When the positively charged organic group has a substitution other than the substitution achieved with a positively charged group, this additional substitution can be with one or more hydroxyl groups, oxygen atoms (thereby forming an aldehyde or ketone group), alkyl groups, and / or additional positively charged groups. The positively charged organic group has a net positive charge because it contains one or more positively charged groups. The terms "positively charged group", "positively charged ionic group", "cationic group", etc. are used interchangeably herein. Positively charged groups include cations (positively charged ions). Examples of positively charged groups include substituted ammonium groups, carbocationic groups, and acyl cationic groups.

[0048] The terms "substituted ammonium group", "substituted ammonium ion" and "substituted ammonium cation" are used interchangeably herein. The substituted ammonium group herein comprises structure I:

[0049]

[0050] R2, R3 and R4 in structure I represent independently of one another hydrogen atom or alkyl, aryl, cycloalkyl, aralkyl or alkaryl. The position of R2, R3 and R4 in structure I is usually not particularly important, and is not intended to cause any specific stereochemistry. The carbon atom (C) in structure I is a part of a chain ("carbon chain") of one or more carbons of a positively charged organic group. The carbon atom is directly ether-connected to a monomer unit (e.g., glucose) of a polysaccharide (e.g., α-glucan) herein, or is ether-connected to a part of a chain of two or more carbon atoms of a monomer unit. The carbon atom in structure I can be -CH2-, -CH- (wherein H is replaced by another group such as a hydroxyl), or -C- (wherein two H are replaced).

[0051] The substituted ammonium group can be a "primary ammonium group", "secondary ammonium group", "tertiary ammonium group" or "quaternary ammonium" group, depending on the composition of R2, R3 and R4 in Structure I. A primary ammonium group herein refers to Structure I in which R2, R3 and R4 are each a hydrogen atom (i.e., -C-NH3 + ). The secondary ammonium group herein refers to the structure I in which R2 and R3 are each a hydrogen atom and R4 is an alkyl, aryl, cycloalkyl, aralkyl, or alkaryl group. The tertiary ammonium group herein refers to the structure I in which R2 is a hydrogen atom and R3 and R4 are each independently an alkyl, aryl, cycloalkyl, aralkyl, or alkaryl group. The quaternary ammonium group herein refers to the structure I in which R2, R3, and R4 are each independently an alkyl, aryl, cycloalkyl, aralkyl, or alkaryl group (i.e., none of R2, R3, and R4 is a hydrogen atom). It should be understood that the fourth member (i.e., R1) implied by the above nomenclature is an ether-linked to one or more carbons (e.g., chains) of a positively charged organic group of a monomer unit (e.g., glucose) of a polysaccharide (e.g., α-glucan) herein.

[0052] For example, the quaternary ammonium polysaccharide ethers herein (e.g., α-glucan ethers) may contain trialkylammonium groups (wherein each of R2, R3, and R4 is an alkyl group). A trimethylammonium group is an example of a trialkylammonium group, where each of R2, R3, and R4 is a methyl group. It should be understood that the fourth member implied by the "quaternary" in this nomenclature (i.e., R1) is a chain of one or more carbons of a positively charged organic group ether-linked to a monomer unit of the polysaccharide.

[0053] An example of a quaternary ammonium polysaccharide ether is trimethylammonium hydroxypropyl polysaccharide. The positively charged organic group of the ether compound can be represented by structure II:

[0054] wherein R2, R3 and R4 are each methyl. Structure II is an example of a quaternary ammonium hydroxypropyl group.

[0055] The terms used herein with respect to "esters" (e.g., polysaccharide ester derivatives) may be as disclosed, for example, in U.S. Patent Application Publication Nos. 2014 / 0187767, 2018 / 0155455, or 2020 / 0308371, or International Patent Application Publication No. WO2021 / 252575, each of which is incorporated herein by reference. The terms "polysaccharide ester derivatives," "polysaccharide ester compounds," "polysaccharide esters," and the like are used interchangeably herein. The polysaccharide ester derivatives herein are polysaccharides that have been esterified with one or more organic groups (i.e., acyl groups) (e.g., charged organic groups, such as anionic or cationic) such that the derivative has a DoS achieved with one or more organic groups of up to about 3.0 (e.g., from about 0.001 to about 3.0). Polysaccharide ester derivatives herein are referred to as polysaccharides due to the inclusion of the substructure -C G -O-CO-C- is called an "ester", where "-C G "-" represents a carbon atom of a monomer unit (e.g., glucose) of the polysaccharide ester derivative (wherein such a carbon atom is bonded to a hydroxyl group [-OH] in the polysaccharide precursor of the ester), and wherein "-CO-C-" is included in the acyl group. Examples of the polysaccharide ester herein include glucan esters (e.g., α- or β-glucan esters).

[0056] The terms "polysaccharide carbamate derivatives", "polysaccharide carbamates", "carbamoyl polysaccharides" and the like are used interchangeably herein. The polysaccharide carbamate derivatives contain a linkage moiety -OCONH- or and thus contains the substructure -C G -OCONH-C R -or-C G -OCON-C R2 -, where "-C G -" represents the carbon of the monomer unit of the polysaccharide carbamate derivative (e.g., glucose), and "-C R -" is contained in an organic group. In some aspects, the nitrogen atom of the carbamate / carbamoyl portion is connected to a hydrogen atom and an organic group. However, in some aspects, the nitrogen atom of the carbamate / carbamoyl portion is connected to two organic groups (such as the above "-C R2 -”), the two organic groups may be the same (e.g., two methyl groups, two ethyl groups) or different (e.g., a methyl group and an ethyl group). Examples of polysaccharide carbamates herein include glucan carbamates (e.g., α- or β-glucan carbamates). The carbamate groups herein may be as disclosed, for example, in International Patent Application Publication No. WO2021 / 252569, which is incorporated herein by reference.

[0057] The terms "polysaccharide sulfonyl derivatives", "sulfonyl polysaccharides" and the like are used interchangeably herein. The polysaccharide sulfonyl derivatives contain the linkage portion -OSO2- and thus contain the substructure -C G -O-SO2-C R -, where "-C G -" represents the carbon of the monomer unit of the polysaccharide sulfonyl derivative (e.g., glucose), and "-C R -" is included in the organic group. The sulfonyl bond herein is non-ionizable. The sulfonyl group of the polysaccharide sulfonyl derivative herein may be as disclosed, for example, in International Patent Application Publication No. WO2021 / 252569, which is incorporated herein by reference.

[0058] The "sulfonate" group herein can be as disclosed, for example, in International Patent Application Publication No. WO2019 / 246228 or U.S. Patent Application Publication No. 2021 / 0253977, which are incorporated herein by reference.

[0059] An additive that "does not chemically react" (and similar terms) with an α-glucan or an α-glucan derivative does not alter the chemical structure of the α-glucan or α-glucan derivative. In some aspects, the presence of the additive does not result in replacement of one or more hydrogens (of the hydroxyl groups of the glucose monomers) with groups derived from the additive (e.g., ether or ester groups, such as any disclosed herein). In some aspects, the presence of the additive does not result in hydrolysis (or other cleavage) of one or more (i) glycosidic bonds and / or (ii) carbon-carbon bonds within the glucose monomers; however, in some aspects, the additive may result in either of these two degradation effects. However, in some aspects, the additive does chemically react with the α-glucan or α-glucan derivative.

[0060] The term "hydrophobic" herein refers to molecules / compounds (e.g., additives herein) or substituents that are non-polar and have little or no affinity for water and tend to repel water. The term "hydrophilic" herein refers to molecules / compounds (e.g., additives herein) or substituents that are polar and have an affinity for interacting with polar solvents (e.g., water) and / or with other polar groups. Hydrophilic molecules or substituents tend to attract water.

[0061] For example, the terms "fiber", "fibers", etc. herein may refer to staple fibers (short-length fibers) or continuous fibers (filaments). For example, the fibers of the present disclosure may include α-1,3-glucan and additives. The fibers may be included in a composition, article, material, or product containing the fibers, such as, for example, a woven product or a nonwoven product.

[0062] As used herein, the term "woven product" and like terms refer to a product formed by weaving, braiding, interweaving or otherwise entangled threads or fibers in an organized, consistent and / or repetitive manner.

[0063] The term "nonwoven" herein, "nonwoven product", "nonwoven web" etc. refers to a web of a single fiber (e.g., filament or staple) inserted into the middle in a random or unrecognizable manner. This contrasts with knitting or woven fabrics, which have a network of recognizable fibers. In some respects, the nonwoven product comprises a nonwoven web that is bonded or attached to another material such as a substrate or backing. In some respects, the nonwoven can further contain a binder or adhesive (reinforcer) that bonds adjacent nonwoven fibers together. Nonwoven binders or adhesive agents can be applied to the nonwoven in the form of, for example, dispersions / latex, solutions, or solids, and then the treated nonwoven is typically dried.

[0064] The terms "fabric", "textile", "cloth", etc. are used interchangeably herein to refer to a woven material having a network of fibers. Such fibers may be in the form of, for example, threads or yarns. However, in some aspects, a fabric may comprise nonwoven fibers.

[0065] As used herein, the terms "fibrids", "fibrillated glucan", etc. may refer to non-granular, fibrous, or film-like particles in which at least one of the three dimensions is of a smaller magnitude relative to the largest dimension. For example, the fibrids of the present disclosure may include α-1,3-glucan and additives. In some aspects, the fibrids may have a fibrous and / or lamellar structure with a relatively large surface area when compared to fibers. The surface area of ​​the fibrids herein may be, for example, about 5 to 50 m 2 / gram of material, wherein the largest dimension is about 10 to 1000 microns and the smallest dimension is 0.05 to 0.25 microns (the aspect ratio of the largest dimension to the smallest dimension is 40 to 20000). In some aspects, fibrids can be defined as the material produced when the caustic solution herein comprising water-insoluble α-glucan (or water-insoluble α-glucan derivative) and additives is subjected to shear forces while also being subjected to conditions that cause the glucan and additive components of the caustic solution to precipitate.

[0066] The terms "film", "sheet" and similar terms herein refer to thin materials that are generally visually continuous. The film may be included on the material as a layer or coating, or may be separate (e.g., not attached to the material surface; free- / self-standing). "Coating" (and similar terms) as used herein refers to a layer covering the surface of a material. For example, the film, sheet, or coating of the present disclosure may include α-1,3-glucan and additives. The term "uniform thickness" as used herein to characterize a film or coating may, for example, refer to a continuous area that is (i) at least 20% of the total film / coating area, and (ii) has a standard deviation of thickness of less than about 50nm. The term "continuous layer" means, for example, a layer of a composition applied to at least a portion of a substrate, wherein the dried layer of the composition covers ≥99% of the surface to which the layer of the composition has been applied and has less than 1% of the voids in the layer exposing the substrate surface. The surface to which the layer has been applied ≥99% does not include any area of ​​the substrate to which the layer has not been applied. In some aspects, the coating herein may form a continuous layer.

[0067] A "composite material" herein is a composition comprising two or more components of the present disclosure (e.g., α-1,3-glucan and an additive). Typically, the components of the composite material resist separation, and one or more of the components exhibit enhanced and / or different properties compared to their individual properties outside the composite material (i.e., the composite material is not just a mixture, which is generally easily separated from its original components). The composite material herein is generally a solid material (typically dry) and can be manufactured via, for example, an extrusion or molding process.

[0068] "Wax" herein typically refers to an ester of a single fatty acid and a single long chain alcohol. Typically, waxes are solid at temperatures below 45°C or 50°C, and / or are aqueous insoluble under both harsh and non-harsh conditions.

[0069] As used herein, the term "oil" typically refers to a lipid that is liquid at 25°C and is hydrophobic and soluble in organic solvents. Oils are typically composed primarily of triacylglycerols, but may also contain other neutral lipids, as well as phospholipids and free fatty acids. For example, oils can be from plant, animal, or mineral sources.

[0070] As used herein, the terms "sequence identity," "identity," and the like with respect to polypeptide amino acid sequences (e.g., polypeptide amino acid sequences of glucosyltransferases) are as in U.S. Patent Application Publication No. 2017 / 0002336, which is incorporated herein by reference.

[0071] As the feature of some embodiments, various polypeptide amino acid sequences are disclosed herein. Variants of these sequences at least about 70%-85%, 85%-90% or 90%-95% identical to the sequences disclosed herein can be used or cited. Alternatively, the variant amino acid sequence can have at least 70%, 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or 99.5% identity with the sequences disclosed herein. The variant amino acid sequences have the same function / activity as the disclosed sequences, or have at least about 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, or 99% of the function / activity of the disclosed sequences.

[0072] The terms "percent by volume," "volume percent," "vol %," "v / v %," and the like are used interchangeably herein. The volume percent of a solute in a solution can be determined using the formula: [(volume of solute) / (volume of solution)] x 100%.

[0073] The terms "percent by weight", "weight percentage (wt%)", "weight-weight percentage (%w / w)", etc. are used interchangeably herein. Weight percentage refers to the percentage of a material on a mass basis when the material is included in a composition, mixture, or solution.

[0074] The terms "weight / volume percent", "w / v%", etc. are used interchangeably herein. The weight / volume percent can be calculated as: ((mass of material [g]) / (total volume of material plus liquid in which the material is placed [mL])) x 100%. A material can be insoluble in the liquid (i.e., a solid phase in a liquid phase, as in the case of a dispersion), or soluble in the liquid (i.e., a solute that dissolves in the liquid).

[0075] The term "isolated" means a substance (or process) that is in a form or in an environment that does not exist in nature. Non-limiting examples of isolated substances include any α-glucan composition disclosed herein. It is believed that the embodiments disclosed herein are synthetic / artificial (impossible to make or practice except for human intervention / involvement), and / or have non-naturally occurring properties.

[0076] As used herein, the term "increased" can refer to a quantity or activity that is at least about 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, 11%, 12%, 13%, 14%, 15%, 16%, 17%, 18%, 19%, 20%, 50%, 100%, or 200% greater than the quantity or activity compared with the increased quantity or activity. The terms "increased," "raised," "enhanced," "greater than," "improved," etc. are used interchangeably herein.

[0077] Some aspects of the present disclosure relate to a solution (caustic solution, stock solution) comprising at least

[0078] (a) Caustic solvents,

[0079] (b) α-glucan and / or its derivatives (or α-glucan which is cross-linked before entering the harsh solvent), and

[0080] (c) an additive, wherein the additive is

[0081] (i) a cross-linking agent (for example, if the α-glucan is not cross-linked prior to exposure to the harsh solvent), and / or

[0082] (ii) optionally an additive that does not chemically react with α-glucan or its derivatives,

[0083] wherein at least about 50% of the glycosidic bonds of the α-glucan are α-1,3 glycosidic bonds, and the weight average degree of polymerization of the α-glucan is at least 15,

[0084] The α-glucan or its derivative is dissolved in the harsh solvent, and the additive is dissolved or insoluble in the harsh solvent.

[0085] Such caustic solutions have several advantageous features. For example, they can be used to produce stock solution filaments comprising the α-glucan and cross-linking agent (or cross-linked α-glucan) herein, which are easier to draw or other types of manipulations than stock solution filaments lacking the cross-linking agent or cross-linked α-glucan. As another example, the caustic solution herein can be used to produce a solid composition of an insoluble α-glucan or a derivative thereof, in which a water-soluble additive is embedded and / or adsorbed; the presence of the water-soluble additive is persistent because it is not easily removed by contacting the solid composition with a non-caustic aqueous liquid.

[0086] The alpha-glucan of the present disclosure is typically water-insoluble under non-caustic conditions herein. Typically, at least about 50% of the glycosidic bonds of the alpha-glucan herein are alpha-1,3 glycosidic bonds. In some aspects, about or at least about 50%, 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, 99.5%, or 100% of the glycosidic bonds of the alpha-glucan are alpha-1,3 glycosidic bonds. Typically, most or all of the glycosidic bonds that are not alpha-1,3 are alpha-1,6. It should be understood that the higher the percentage of alpha-1,3 bonds present in the alpha-glucan, the greater the probability that the glucan is a straight chain, because the incidence of certain bonds that may be part of a branch point is lower. In some aspects, the α-glucan has no branch points or has less than about 5%, 4%, 3%, 2%, or 1% (as a percentage of glycosidic bonds in the α-glucan) branch points.

[0087] For example, the α-glucans of the present disclosure can have a DPw, DPn, or DP of at least about 15. In some aspects, the DPw, DPn, or DP of the α-glucans can be about, less than about, at least about, or more than about 10, 15, 20, 25, 30, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 65, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95 400, 500, 600, 700, 800, 900, 1000, 1100, 1200, 1300, 1400, 1500, 1600, 1700, 1800, 1900, 2000, 2500, 3000, 3500, or 4000. DPw, DPn, or DP may alternatively be expressed as a range between any two of these values. By way of example only, the DPw, DPn, or DP of the α-glucan herein may be about 15-1600, 50-1600, 100-1600, 200-1600, 300-1600, 400-1600, 500-1600, 600-1600, 700-1600, 15-1250, 50-1250, 100-1250, 200-1250, 300-1250, 400-1250, 500-1250, 600-12 -1000, 50-600, 100-900, 200-900, 300-900, 400-900, 500-900, 600-900, 700-900, 600-800, or 600-750. By way of further example only, the DPw, DPn, or DP of the alpha-glucans herein may be about 15-100, 25-100, 35-100, 15-80, 25-80, 35-80, 15-60, 25-60, 35-60, 15-55, 25-55, 35-55, 15-50, 25-50, 35-50, 35-45, 35-40, 40-100, 40-80, 40-60, 40-55, 40-50, 45-60, 45-55, 45-50, 15-35, 20-35, 15-30, or 20-30.As further examples only, DPw, DPn, or DP may be about 100-600, 100-500, 100-400, 100-300, 200-600, 200-500, 200-400, or 200-300. In some aspects, the α-glucan can have a high molecular weight as reflected by a high intrinsic viscosity (IV); for example, the IV can be about or at least about 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 6-8, 6-7, 6-22, 6-20, 6-17, 6-15, 6-12, 10-22, 10-20, 10-17, 10-15, 10-12, 12-22, 12-20, 12-17, or 12-15 dL / g (for comparison purposes, note that the IV of an insoluble α-glucan having at least 90% (e.g., about 99% or 100%) α-1,3 bonds and a DPw of about 800 has an IV of about 2-2.5 dL / g). For example, IV herein can be as measured with an insoluble α-glucan polymer dissolved in DMSO with about 0.9 to 2.5 wt % (eg, 1, 2, 1-2 wt %) LiCl.

[0088] The α-glucan herein can be as disclosed, for example, in the following (e.g., molecular weight, bond pattern, and / or production method): U.S. Patent Nos. 7,000,000, 8,871,474, 1,0301,604, or 1,026,0053, or U.S. Patent Application Publication Nos. 2019 / 0112456, 2019 / 0078062, 2019 / 0078063, 2018 / 0340199, 2018 / 0021238, 2018 / 0273731, 2017 / 0002335, 2015 / 0232819, 2015 / 0064748, 2020 / 0165360, 2020 / 0131281, or 2019 / 0185893, each of which is incorporated herein by reference. α-glucan can be produced, for example, by an enzymatic reaction comprising at least water, sucrose, and a glucosyltransferase that synthesizes α-glucan. It is contemplated that the glucosyltransferase, reaction conditions, and / or methods that can be used to produce α-glucan can be as disclosed in any of the aforementioned references.

[0089] In some aspects, the glucosyltransferase used to produce the α-glucans herein can comprise a glucosyltransferase that is identical to SEQ ID NO: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 26, 28, 30, 34, or 59, or amino acid residues 55-960 of SEQ ID NO: 4, residues 54-957 of SEQ ID NO: 65, residues 55-960 of SEQ ID NO: 30, residues 55-960 of SEQ ID NO: 28, or residues 55-960 of SEQ ID NO: 20. Amino acid sequences that are 100% identical or at least 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 98.5%, 99%, or 99.5% identical, and have glucosyltransferase activity; these amino acid sequences are disclosed in U.S. Patent Application Publication No. 2019 / 0078063, which is incorporated herein by reference. It should be noted that the glucosyltransferase comprising SEQ ID NO: 2, 4, 8, 10, 14, 20, 26, 28, 30, 34, or amino acid residues 55-960 of SEQ ID NO: 4, residues 54-957 of SEQ ID NO: 65, residues 55-960 of SEQ ID NO: 30, residues 55-960 of SEQ ID NO: 28, or residues 55-960 of SEQ ID NO: 20 can synthesize α-glucans containing at least about 90% (about 100%) α-1,3 bonds.

[0090] In some aspects, the α-glucan can be in the form of a graft copolymer, such as disclosed in International Patent Application Publication No. WO2017 / 079595 or U.S. Patent Application Publication No. 2020 / 0165360, 2019 / 0185893, or 2020 / 0131281, which are incorporated herein by reference. The graft copolymer may comprise dextran (as a backbone) and α-1,3-glucan (as one or more side chains), wherein the latter component has been grafted onto the former component; typically, such a graft copolymer is produced by using dextran or α-1,2- and / or α-1,3-branched dextran as a primer for α-1,3-glucan synthesis performed by a glucosyltransferase that produces α-1,3-glucan as described above. One or more α-1,3-glucan side chains of the α-glucan graft copolymer herein may be α-1,3-glucan as disclosed in the present invention. The dextran backbone of the α-glucan graft copolymer herein may comprise about 100% α-1,6 glycosidic bonds (i.e., a completely linear dextran backbone) or about or at least about 80%, 85%, 90%, 95%, 96%, 97%, 98%, 99%, or 99.5% α-1,6 glycosidic bonds (i.e., a substantially linear dextran backbone), and / or have, for example, about, at least about, or less than about 100% α-1,6 glycosidic bonds. about 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 35, 40, 45, 50, 85, 90, 95, 100, 105, 110, 150, 200, 250, 300, 400, 500, 600, 700, 800, 900, 1000, 8-20, 8-30, 8-100, 8-500, 3-4, 3-5, 3-6, 3-7, 3-8, 4-5, 4-6, 4-7, 4-8, 5-6, 5-7, 5-8, 6-7, 6-8, 7-8, 90-120, 95-120, 100-120, 105-120, 110-120, 115 -120, 90-115, 95-115, 100-115, 105-115, 110-115, 90-110, 95-110, 100-110, 105-110, 90-105, 95-105, 100-105, 90-100, 95-100, 90-95, 85-95, or 85-90 DP, DPw, or DPn.In some aspects, the molecular weight of the dextran backbone can be about, or at least about 0.1, 0.125, 0.15, 0.175, 0.2, 0.24, 0.25, 0.5, 0.75, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 20, 30, 40, 50, 60, 70, 80, 90, 100, 110, 120, 130, 140, 150, 160, 170, 180, 190, 200, 0 .1-0.2, 0.125-0.175, 0.13-0.17, 0.135-0.165, 0.14-0.16, 0.145-0.155, 5-15, 10-80, 20-70, 30-60, 40-50, 50-200, 60-200, 70-200, 80-200, 90-200, 100-200, 110-200, 120-200, 50-180, 6 0-180, 70-180, 80-180, 90-180, 100-180, 110-180, 120-180, 50-160, 60-160, 70-160, 80-160, 90-160, 100-160, 110-160, 120-160, 50-140, 60-140, 70-140, 80-140, 90-140, 100-140, 110-140 0, 120-140, 50-120, 60-120, 70-120, 80-120, 90-120, 90-110, 100-120, 110-120, 50-110, 60-110, 70-110, 80-110, 90-110, 100-110, 50-100, 60-100, 70-100, 80-100, 90-100, or 95-105 million Daltons. In some aspects, the dextran backbone (before being incorporated into the graft copolymer) has been or is α-1,2- and / or α-1,3-branched; the α-1,2 and / or α-1,3 branching percentage of the backbone of the graft copolymer herein can be, for example, about, at least about, or less than about 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, 11%, 12%, 13%, 14%, 15%, 16%, 17%, 18%, 19%, 20%, 21%, 22%, 23%, 24%, 25%, 26%, 27%, 28%, 29%, 30%, 31%, 32%, 33%, 34%, 35%, 36%, 37%, 38%, 39%, 40%, 41%, 42%, 43%, 44%, 45%, 46%, 47%, 48%, 49%, 50%, 51%, 52%, 53%, 54%, 55%, 56%, 57%, 58%, 59%, 60%, 61%, 62%, 63%, 64%, 65%, 66%, 67%, 68%, 69%, 70%, 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, 25%, 30%, 35%, 40%, 45%, 50%, 2%-25%, 2%-20%, 2%-15%, 2%-10%, 5%-25%, 5%-20%, 5%-15%, 5%-10%, 7%-13%, 8%-12%, 9%-11%, 10%-25%, 10%-20%, 10%-15%, 10%-22%, 12%-20%, 12%-18%, 14%-20%, 14%-18%, 15%-18%, or 15%-17%.The dextran portion of the graft copolymer herein can be as disclosed, for example, in U.S. Patent Application Publication Nos. 2016 / 0122445, 2017 / 0218093, 2018 / 0282385, 2020 / 0165360, or 2019 / 0185893 (e.g., molecular weight, bond / branching profiles, production methods), each of which is incorporated herein by reference. In some aspects, dextran can be a dextran produced in a suitable reaction comprising glucosyltransferase (GTF) 0768 (SEQ ID NO: 1 or 2 of US2016 / 0122445), GTF 8117, GTF6831, or GTF 5604 (the latter three GTF enzymes are SEQ ID NO: 30, 32, and 33 of US2018 / 0282385, respectively), or a GTF comprising an amino acid sequence that is at least 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, or 99% identical to the amino acid sequence of GTF 0768, GTF 8117, GTF 6831, or GTF 5604.

[0091] The caustic solutions herein may comprise one, two, three or more different α-glucans herein (eg, differing in the percentage of DPw and / or α-1,3 linkages).

[0092] Any α-glucan disclosed herein can be derivatized and used in the caustic solution herein or other compositions herein (e.g., fibers, fibrids, composites, or films / coatings). For example, the α-glucan portion of the α-glucan derivative herein can have a molecular weight (e.g., DP, DPw, or DPn) and / or glycosidic bond profile as disclosed herein for α-glucans. By way of example only, the α-glucans herein that can be derivatized can include (i) α-glucans (e.g., having ≥ about 50%, 90%, 95%, 99%, or 100% α-1,3 bonds) having a DPw greater than 15 (e.g., ≥ 100, 400, 600) or (ii) α-glucan graft copolymers herein. In some aspects, the α-glucan derivative can have a degree of substitution (DoS) of up to about 3.0 achieved with at least one substituent (e.g., an organic group) as disclosed herein. The organic groups herein can be uncharged (nonionic) or charged (e.g., cationic [positively charged] or anionic [negatively charged]). In some aspects, the degree of substitution (DoS) can be about, at least about, or up to about 0.001, 0.0025, 0.005, 0.01, 0.025, 0.05, 0.075, 0.1, 0.2, 0.25, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1.0, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, 2.0, 2.1, 2.2, 2.3, 2.4, 2.5, 2.6, 2.7, 2.8, 2.9, or 3.0 (DoS can alternatively be expressed as a range between any two of these values).Some examples of DoS ranges herein include 0.001-3.0, 0.001-2.0, 0.001-1.5, 0.001-1.25, 0.001-1.0, 0.001-0.9, 0.001-0.8, 0.001-0.7, 0.001-0.6, 0.001-0.5, 0.005-3.0, 0.005-2.0, 0.005-1.5, 0.005-1.25, 0.005-1.0, 0.005-0.9, 0.005-0.8, 0.005-0.7, 0.005-0.6, 0.005-0.5, 0.01-3.0 、0.01-2.0、0.01-1.5、0.01-1.25、0.01-1.0、0.01-0.9、0.01-0.8、0.01-0.7、0.01-0.6、0.01-0.5、0.05-3.0、0.05-2.0、0.05-1.5、0.05-1.25、0.05-1.0、0.05-0.9、0.05-0.8、0.05-0.7、0.05-0.6、0.05-0.5、0.1-3.0、0.1-2.0、0.1-1.5、0.1-1.25、0.1-1.0、0.1-0.9、0.1- 0.8, 0.1-0.7, 0.1-0.6, 0.1-0.5, 0.15-3.0, 0.15-2.0, 0.15-1.5, 0.15-1.25, 0.15-1.0, 0.15-0.9, 0.15-0.8, 0.15-0.7, 0.15-0.6, 0.15-0.5, 0.2-3.0, 0.2-2.0, 0.2-1.5, 0.2-1.25, 0.2-1.0, 0.2-0.9, 0.2-0.8, 0.2-0.7, 0.2-0.6, 0.2-0.5, 0.25-3.0, 0.25-2.0, 0.25-1.5 , 0.25-1.25, 0.25-1.0, 0.25-0.9, 0.25-0.8, 0.25-0.7, 0.25-0.6, 0.25-0.5, 0.3-3.0, 0.3-2.0, 0.3-1.5, 0.3-1.25, 0.3-1.0, 0.3-0.9, 0.3-0.8, 0.3-0.7, 0.3-0.6, 0.3-0.5, 0.4-3.0, 0.4-2.0, 0.4-1.5, 0.4-1.25, 0.4-1.0, 0.4-0.9, 0.4-0.8, 0.4-0.7, 0.4-0.6 and 0.4-0.5.

[0093] The α-glucan derivative can be used to replace or supplement the non-derivatized α-glucan used in part (b) of the caustic solution. Also for example, the α-glucan derivative can be used as an additive in part (c) of the caustic solution. The α-glucan derivative of part (b) of the caustic solution herein is typically water-insoluble under non-caustic aqueous conditions. The α-glucan derivative can be charged (e.g., cationic or anionic), for example (when used as an additive, such as an example of a charged additive). The degree of substitution (DoS) of the charged, aqueous-insoluble α-glucan derivative under non-harsh aqueous conditions is typically about, or less than about 0.29, 0.25, 0.2, 0.15, 0.1, 0.05, 0.05-0.29, 0.05-0.25, 0.05-0.2, 0.05-0.15, 0.1-0.29, 0.1-0.25, 0.1-0.2, or 0.1-0.15 (generally, a higher DoS [over 0.3 or more] renders it aqueous-soluble under non-harsh aqueous conditions). In some aspects, any of the foregoing characteristics can also characterize the α-glucan derivative used as an additive herein (part [c] of the caustic solution). For example, the type of derivative (e.g., water-insoluble or water-soluble under non-caustic aqueous conditions) (e.g., for use in section [b] or section [c] of the caustic solutions herein) can be any derivative as disclosed herein (e.g., ether, ester).

[0094] In some aspects, the aqueous soluble (under non-caustic conditions) α-glucan derivative (e.g., can be an additive in section [c] of a caustic solution herein) can have a degree of substitution (DoS) of up to about 3.0 (e.g., 0.3 to 3.0) with at least one organic group / substituent as disclosed herein. Such an organic group is typically charged; that is, the organic group can be a cationic or anionic. The DoS can be, for example, about or at least about 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1.0, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, 2.0, 2.1, 2.2, 2.3, 2.4, 2.5, 2.6, 2.7, 2.8, 2.9, or 3.0 (the DoS can alternatively be expressed as a range between any two of these values). Some examples of DoS ranges of the soluble α-glucan derivatives herein under non-harsh aqueous conditions include 0.3-3.0, 0.3-2.5, 0.3-2.0, 0.3-1.75, 0.3-1.5, 0.3-1.25, 0.3-1.0, 0.3-0.9, 0.3-0.8, 0.3-0.7, 0.3-0.6, 0.3-0.5, 0.4-3.0, 0.4-2.5, 0.4-2.0, 0.4-1.75, 0.4-1.5, 0.4-1.25, 0.4-1.0, 0.4-0.9, 0.4-0.8, 0.4-0.7, 0.4-0.6, 0.4-0.5, 0.4-0. -3.0, 0.5-2.5, 0.5-2.0, 0.5-1.75, 0.5-1.5, 0.5-1.25, 0.5-1.0, 0.5-0.9, 0.5-0.8, 0.5-0.7, 0.5-0.6, 0.6-3.0, 0.6-2.5, 0.6-2.0, 0.6-1.75, 0.6-1.5, 0.6-1.25, 0.6-1.0, 0.6-0.9, 0.6-0.8, 0.6-0.7, 0.8-3.0, 0.8-2.5, 0.8-2.0, 0.8-1.75, 0.8-1.5, 0.8-1.25, 0.8-1.0 and 0.8-0.9.

[0095] Typically, α-glucan derivatives that are insoluble under non-harsh aqueous conditions can be used in part (b) and / or part (c) of the caustic solution herein (if both [b] and [c], two different derivatives are typically used). Typically, α-glucan derivatives that are soluble under non-harsh aqueous conditions can be used as additives in part (c) of the caustic solution herein. In some aspects, if part (b) comprises a water-insoluble α-glucan, the part (c) additive comprises an α-glucan derivative. In some aspects, if the part (c) additive comprises an α-glucan derivative, the part (b) does not comprise an α-glucan derivative (or polysaccharide derivative).

[0096] In some aspects, the α-glucan derivative (e.g., insoluble or soluble under non-harsh aqueous conditions, depending on the DoS and the type of derivative) is substituted with at least one organic group herein via an ether bond, an ester bond, a carbamate bond, or a sulfonyl bond. Thus, the α-glucan derivative herein can be, for example, an α-glucan ether, ester, carbamate, or sulfonyl derivative. All of the various linking groups disclosed herein are examples of organic groups; for example, an organic group can be considered to contain at least one carbon atom and at least one hydrogen atom.

[0097] In some aspects, the α-glucan derivative can be an ether derivative.

[0098] The organic group in the ether bond with the α-glucan herein may include, for example, a positively charged (cationic) group or be composed thereof. The positively charged group may be, for example, any of those disclosed in U.S. Patent Application Publication Nos. 2016 / 0311935 or 2020 / 0002646, or International Patent Application Publication Nos. WO2021 / 247810 or WO 2021257786, or U.S. Patent Application No. 63 / 276,163, which are incorporated herein by reference. For example, the positively charged group may include a substituted ammonium group. Examples of substituted ammonium groups are primary, secondary, tertiary and quaternary ammonium groups, such as those represented by structures I and II. For example, the ammonium group may be substituted by one or more alkyl groups and / or one or more aryl groups. In some aspects, one, two, or three alkyl and / or aryl groups may be present. The alkyl group of the substituted ammonium group herein may be C1-C 30 Alkyl, such as, for example, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, nonyl, decyl, undecyl, dodecyl, tridecyl, tetradecyl, pentadecyl, hexadecyl, heptadecyl, octadecyl, nonadecyl, eicosyl, heneicosyl, docosyl, tricosyl, tetracosyl, C 25 , C 26 , C 27 , C28 , C 29 , or C 30 Each alkyl group can be the same or different, and in some aspects has two or three alkyl substitutions. In some aspects, the alkyl group can be C1-C 24 、C1-C 18 、C6-C 20 , C 10 -C 16 , or C1-C4. Aryl can be, for example, C6, C6-C 24 , C 12 -C 24 , or C6-C 18 Aryl groups are optionally substituted with one or more alkyl substituents (eg, any alkyl group disclosed herein).

[0099] In some aspects, the secondary ammonium α-glucan ethers herein can comprise a monoalkylammonium group (e.g., based on Structure I). In some aspects, the secondary ammonium α-glucan ethers can be monoalkylammonium α-glucan ethers, such as monomethyl-, monoethyl-, monopropyl-, monobutyl-, monopentyl-, monohexyl-, monoheptyl-, monooctyl-, monononyl-, monodecyl-, monoundecyl-, monododecyl-, monotridecyl-, monotetradecyl-, monopentadecyl-, monohexadecyl-, monoheptadecyl-, or monooctadecyl-ammonium α-glucan ethers. These α-glucan ethers can also be referred to as methyl-, ethyl-, propyl-, butyl-, pentyl-, hexyl-, heptyl-, octyl-, nonyl-, decyl-, undecyl-, dodecyl-, tridecyl-, tetradecyl-, pentadecyl-, hexadecyl-, heptadecyl-, or octadecyl-ammonium α-glucan ethers, respectively.

[0100] In some aspects, the tertiary ammonium α-glucan ethers herein can comprise a dialkylammonium group (e.g., based on Structure I). In some aspects, the tertiary ammonium α-glucan ether can be a dialkylammonium α-glucan ether, such as dimethyl-, diethyl-, dipropyl-, dibutyl-, dipentyl-, dihexyl-, diheptyl-, dioctyl-, dinonyl-, didecyl-, diundecyl-, didodecyl-, ditridecyl-, ditetradecyl-, dipentadecyl-, dihexadecyl-, diheptadecyl-, or dioctadecyl-ammonium α-glucan ether.

[0101] In some aspects, the quaternary ammonium α-glucan ethers herein can comprise a trialkylammonium group (e.g., based on Structure I). In some aspects, the quaternary ammonium α-glucan ether compound can be a trialkylammonium α-glucan ether, such as trimethyl-, triethyl-, tripropyl-, tributyl-, tripentyl-, trihexyl-, triheptyl-, trioctyl-, trinonyl-, tridecyl-, tri-undecyl-, tri-dodecyl-, tri-tridecyl-, tri-tetradecyl-, tri-pentadecyl-, tri-hexadecyl-, tri-heptadecyl-, or tri-octadecyl-ammonium α-glucan ether.

[0102] One of the groups of the substituted ammonium group contains a carbon, or carbon (e.g., up to 30) chain in the ether bond to the α-glucan. In this case, the carbon chain can be, for example, linear. Such a carbon or carbon chain can be composed of, for example, -CH2-, -CH2CH2-, -CH2CH2CH2-, -CH 2( CH2)2CH2-、-CH 2( CH2)3CH2-、-CH 2( CH2)4CH2-、-CH 2( CH2)5CH2-、-CH2 ( CH2)6CH2-、-CH 2( CH2)7CH2-、-CH 2( CH2)8CH2-、-CH 2( CH2)9CH2-, or -CH 2( CH2) 10CH2- represents. In some aspects, in this case, the carbon chain can be branched, such as by being replaced by one or more alkyl groups (for example, any as disclosed above, such as methyl, ethyl, propyl or butyl). One or more substitution points can be at any position along the carbon chain. The example of branched carbon chain includes-CH(CH3)CH2-,-CH(CH3)CH2CH2-,-CH2CH(CH3)CH2-,-CH(CH2CH3)CH2-,-CH(CH2CH3)CH2CH2-,-CH2CH(CH2CH3)CH2-,-CH(CH2CH2CH3)CH2-,-CH(CH2CH2CH3)CH2-,-CH(CH2CH2CH3)CH2-,-CH(CH2CH2CH3)CH2- and-CH2CH(CH2CH2CH3)CH2-; if necessary, longer branched carbon chains can also be used. In some aspects, the chain of one or more carbons (for example, any one of the above-mentioned straight or branched chains) is further replaced by one or more hydroxyl groups. Examples of hydroxy- or dihydroxy(diol)-substituted chains include -CH(OH)-, -CH(OH)CH2-, -C(OH)2CH2-, -CH2CH(OH)CH2-, -CH(OH)CH2CH2-, -CH(OH)CH(OH)CH2-, -CH2CH2CH(OH)CH2-, -CH2CH(OH)CH2CH2-, -CH(OH)CH2CH2-, -CH2CH(OH)CH(OH)CH2-, -CH(OH)CH2CH2-, -CH2CH(OH)CH(OH)CH2-, -CH(OH)CH(OH)CH2CH2-, and -CH(OH)CH2CH(OH)CH2-. In each of the foregoing examples, the first carbon atom of the chain is linked to the glucose monomer ether of the α-glucan, and the last carbon atom of the chain is linked to a positively charged group (e.g., a substituted ammonium group as disclosed herein). In some aspects, the one or more positively charged organic groups can comprise a trimethylammonium hydroxypropyl group (Structure II, when R2, R3, and R4 are each methyl).

[0103] In the aspect of substitution in which the carbochain of the positively charged organic group has substitutions other than substitutions with positively charged groups, such additional substitutions can be carried out with, for example, one or more hydroxyls, oxygen atoms (thereby forming aldehyde or keto groups), alkyls (e.g., methyl, ethyl, propyl, butyl), and / or additional positively charged groups. Positively charged groups are typically bonded to the terminal carbon atoms of the carbochain. In some aspects, positively charged groups can also include compounds containing imidazoline rings.

[0104] The counterion of the positively charged organic group herein can be any suitable anion, such as acetate, borate, bromate, bromine, carbonate, chlorate, chlorine, chlorite, dihydrogen phosphate, fluorine, bicarbonate, hydrogen phosphate, hydrogen sulfate, hydrogen sulfide, hydrogen sulfite, hydroxide, hypochlorite, iodate, iodine, nitrate, nitrogen, nitrite, oxalate, oxygen, perchlorate, permanganate, phosphate, phosphorus, phosphite, silicate, stannate, stannate, sulfate, sulfur, sulfite, tartrate, or thiocyanate anion.

[0105] The organic group in the ether bond with the α-glucan herein may, for example, include or be composed of a negatively charged (anionic) group. Anionic groups may be, for example, any of those disclosed in U.S. Patent Application Publication Nos. 2016 / 0311935 or 2020 / 0002646, or International Patent Application Publication Nos. WO2021 / 252569 or WO2021 / 247810, which are incorporated herein by reference. Anionic groups herein may include substituted alkyl groups, wherein the alkyl groups have one, two, or more substitutions with at least one anionic group. Substituted alkyl groups may be substituted methyl, ethyl, propyl, butyl, amyl, hexyl, heptyl, octyl, nonyl, decyl, undecyl, dodecyl, tridecyl, tetradecyl, pentadecyl, hexadecyl, heptadecanyl, or octadecyl. The anionic groups of substituted alkyl groups may be, for example, carboxyl groups; that is, anionic groups herein may include carboxyalkyl groups. Examples of suitable carboxyalkyl groups herein include carboxymethyl (-CH2COOH), carboxyethyl (e.g., -CH2CH2COOH, -CH(COOH)CH3), carboxypropyl (e.g., -CH2CH2CH2COOH, -CH2CH(COOH)CH3, -CH(COOH)CH2CH3), carboxybutyl and carboxypentyl. In addition to being substituted with at least one anionic group, the substituted alkyl group may also be optionally further substituted with at least one other group such as an alkyl or hydroxyl group.

[0106] The organic group in ether linkage with the α-glucan herein can include, for example, or be composed of, an alkyl group. In some aspects, the alkyl group can be linear, branched, or cyclic ("cycloalkyl" or "alicyclic"). In some aspects, the alkyl group is C1 to C 18 Alkyl, such as C4 to C 18 Alkyl, or C1 to C 10 Alkyl (in "C #”, # refers to the number of carbon atoms in the alkyl group). The alkyl group can be, for example, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, nonyl, decyl, undecyl, dodecyl, tridecyl, tetradecyl, pentadecyl, hexadecyl, heptadecyl, or octadecyl; such alkyl groups are typically straight-chain. In some aspects, one or more carbons of the alkyl group can be substituted with another alkyl group, so that the alkyl group is branched. Suitable examples of branched isomers of straight-chain alkyl groups include isopropyl, isobutyl, tert-butyl, sec-butyl, isopentyl, neopentyl, isohexyl, neohexyl, 2-ethylhexyl, 2-propylheptyl, and isooctyl. In some aspects, the alkyl group is a cycloalkyl group such as cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, cyclononyl, or cyclodecyl.

[0107] Alternatively, the etherified alkyl groups herein may contain one or more heteroatoms, such as oxygen, sulfur, and / or nitrogen, within the hydrocarbon chain. Examples include alkyl groups containing alkylglycerol alkoxylate moieties (-alkylene-OCH2CH(OH)CH2OH), moieties derived from the ring opening of 2-ethylhexyl glycidyl ether, and tetrahydropyranyl (e.g., such as derived from dihydropyran). Additional examples include alkyl groups substituted at their ends with cyano (-C≡N); such substituted alkyl groups may alternatively be referred to as nitrile or cyanoalkyl groups. Examples of cyanoalkyl groups herein include cyanomethyl, cyanoethyl, cyanopropyl, and cyanobutyl.

[0108] In some aspects, the etherified organic group comprises C2 to C 18 (For example, C4 to C 18 ) alkenyl or consisting of it, and the alkenyl group can be straight chain, branched or cyclic. As used herein, the term "alkenyl" refers to a hydrocarbon group containing at least one carbon-carbon double bond. Examples of alkenyl groups include vinyl, propenyl, butenyl, pentenyl, hexenyl, cyclohexyl and allyl. In some aspects, one or more carbons of the alkenyl group can have one or more substitutions with alkyl, hydroxyalkyl or dihydroxyalkyl, as disclosed herein. Examples of such substituted alkyl groups include methyl, ethyl and propyl. Alternatively, the alkenyl group herein can contain one or more heteroatoms in the hydrocarbon chain, such as oxygen, sulfur and / or nitrogen; for example, the alkenyl group can contain a portion derived from the ring opening of allyl glycidyl ether.

[0109] In some aspects, the etherified organic group comprises C2 to C 18 Alkynyl or consisting of it. As used herein, the term "alkynyl" refers to a straight and branched hydrocarbon group containing at least one carbon-carbon triple bond. Alkynyl herein can be, for example, propynyl, butynyl, pentynyl or hexynyl. Alkynyl can alternatively be substituted by, for example, alkyl, hydroxyalkyl, and / or dihydroxyalkyl. Alternatively, alkynyl can contain one or more heteroatoms, such as oxygen, sulphur, and / or nitrogen in the hydrocarbon chain.

[0110] In some aspects, the etherified organic group comprises or consists of a polyether comprising repeating units of (—CH2CH2O—), (—CH2CH(CH3)O—), or a mixture thereof, wherein the total number of repeating units is in the range of 2 to 100. In some aspects, the organic group is a polyether comprising (—CH2CH2O—) 3-100 or (-CH2CH2O-) 4-100 In some aspects, the organic group is a polyether group comprising (-CH2CH(CH3)O-) 3-100 or (-CH2CH(CH3)O-) 4-100 As used herein for polyether groups, subscripts specifying a range of values ​​represent the potential number of repeating units; for example, (CH2CH2O) 2-100 It means a polyether group containing 2 to 100 repeating units. In some aspects, the polyether groups herein can be terminated, such as with methoxy, ethoxy, or propoxy groups.

[0111] In some respects, the etherified organic group comprises an aryl or is composed of an aryl. As used herein, the term "aryl" means an aromatic / carbocyclic group with a monocyclic (e.g., phenyl), polycyclic (e.g., biphenyl), or multiple condensed rings, at least one of which is aromatic (e.g., 1,2,3,4-tetrahydronaphthyl, naphthyl, anthracenyl, or phenanthrenyl), which is optionally monosubstituted, disubstituted, or trisubstituted by one or more alkyls such as methyl, ethyl, or propyl (or any other alkyl herein). In some respects, an aryl is C6 to C 20 Aryl. In some respects, aryl is a methyl-substituted aryl, such as tolyl (-C6H4CH3) or xylyl [-C6H3(CH3)2] group. Tolyl can be, for example, p-tolyl. In some respects, aryl is benzyl (-CH2-phenyl). Benzyl herein can be optionally substituted (typically on its phenyl ring) by one or more of halogen, cyano, ester, amide, ether, alkyl (e.g., C1 to C6), aryl (e.g., phenyl), alkenyl (e.g., C2 to C6) or alkynyl (e.g., C2 to C6) groups.

[0112] In some aspects, the α-glucan ether may contain one type of etherified organic group herein. However, in some aspects, the α-glucan ether may contain two or more different types of etherified organic groups herein (i.e., mixed ethers of α-glucans). Examples of such α-glucan ethers contain (i) two different alkyl groups as etherified organic groups, (ii) an alkyl group and a hydroxyalkyl group as etherified organic groups (alkylhydroxyalkyl α-glucans), (iii) an alkyl group and a carboxyalkyl group as etherified organic groups (alkylcarboxyalkyl α-glucans), (iv) a hydroxyalkyl group and a carboxyalkyl group as etherified organic groups (hydroxyalkylcarboxyalkyl α-glucans), (v) two different hydroxyalkyl groups as etherified organic groups, (vi) two different carboxyalkyl groups as etherified organic groups, (vii) a carboxyalkyl group and an aryl group (e.g., benzyl). Non-limiting examples of some of these types of mixed ethers include ethyl hydroxyethyl α-glucan, hydroxyalkylmethyl (e.g., hydroxypropylmethyl) α-glucan, carboxymethylhydroxyethyl α-glucan, carboxymethylhydroxypropyl α-glucan, and carboxymethylbenzyl α-glucan. In some cases, the mixed α-glucan ethers may be as disclosed in U.S. Patent Application Publication No. 2020 / 0002646, which is incorporated herein by reference.

[0113] In some aspects, the α-glucan derivative can be an ester derivative. The acyl group of the α-glucan ester derivative herein can be as disclosed in, for example, U.S. Patent Application Publication Nos. 2014 / 0187767, 2018 / 0155455, or 2020 / 0308371, or International Patent Application Publication No. WO2021 / 252575, each of which is incorporated herein by reference.

[0114] In some aspects, the α-glucan derivatives herein can be α-glucan carbamates. The α-glucan carbamate derivatives can include, for example, carbamate groups derived from aliphatic, alicyclic, or aromatic monoisocyanates. In some aspects, the substituents of the α-glucan carbamate derivatives can be phenyl, benzyl, diphenylmethyl, or diphenylethyl connected to carbamates; these groups can be optionally derived from aromatic monoisocyanates such as phenyl, benzyl, diphenylmethyl, or diphenylethyl isocyanates, respectively. In some aspects, the substituents of the α-glucan carbamate derivatives can be ethyl, propyl, butyl, tert-butyl, amyl, hexyl, heptyl, octyl, nonyl, decyl, undecyl, or octadecyl connected to carbamates; these groups can be optionally derived from aliphatic monoisocyanates such as ethyl, propyl, butyl, tert-butyl, amyl, hexyl, heptyl, octyl, nonyl, decyl, undecyl, or octadecyl isocyanates, respectively. In some aspects, the substituents of the α-glucan carbamate derivatives can be carbamate-linked cyclohexyl, cycloheptyl, or cyclododecyl groups; these groups can be optionally derivatized using alicyclic monoisocyanates such as cyclohexyl, cycloheptyl, or cyclododecyl isocyanate, respectively.

[0115] The carbamate group of the α-glucan carbamate derivative herein may be as disclosed, for example, in International Patent Application Publication Nos. WO2020 / 131711 or WO2021 / 252569, or U.S. Patent Application Publication No. 2022 / 0033531, each of which is incorporated herein by reference.

[0116] In some aspects, the α-glucan derivative can be an α-glucan sulfonyl derivative. The sulfonyl group of the α-glucan sulfonyl derivative herein can be as disclosed in, for example, International Patent Application Publication No. WO2021 / 252569, which is incorporated herein by reference.

[0117] In some aspects, the α-glucan derivatives can have carboxylate (carboxylic acid) groups. For example, the carboxylic acid group can exist alone (e.g., carbon 6 of glucose can be -COOH), or via (i) an α-glucan ether-, ester-, carbamate-, or sulfonyl-linked and (ii) an organic group (e.g., carboxyalkyl, such as carboxymethyl) containing the carboxylic acid group. In some aspects, the carboxyl group can be introduced by oxidizing the α-glucan or α-glucan derivative (e.g., at carbon 6 of glucose and / or at the carbon of a substituent); the oxidation can be carried out via methods disclosed in, for example, Canadian Patent Publication Nos. 2028284 or 2038640, or U.S. Patent Nos. 4985553, 2894945, 5747658, or 7595392, or U.S. Patent Application Publication Nos. 2015 / 0259439, 2018 / 0022834, or 2018 / 0079832, or U.S. Patent Application Nos. 63 / 151,223 or 63 / 151,237, or International Patent Application Publication Nos. WO2022 / 178075 or WO2022 / 178073, each of which is incorporated herein by reference.

[0118] Thus, polysaccharides other than α-1,3-glucans as disclosed herein may be derivatized and used herein. For example, such derivatization may be as disclosed above (e.g., DoS, derivative type, substituent[s]). In some additional or alternative aspects, non-derivatized polysaccharides may be used. In some aspects, the polysaccharide can be a fructan, a galactan, a mannan, an arabinan, a xylan, a soybean polysaccharide, a chitosan, a chitin, a glycosaminoglycan (e.g., heparan sulfate, dermatan sulfate, heparin), a glucosamine, a carrageenan, an alginate, a xanthan gum, a guar gum, a cyclodextrin, a gellan gum, a curdlan, a β-glucan (e.g., β-1,4-glucan [cellulose], β-1,3-glucan), or an α-glucan that is not an α-1,3-glucan herein (e.g., α-1,6-glucan, α-1,4-glucan, alternan, reuteran, amylopectin, optionally having α-1,2 and / or α-1,3-glucan branches). In some aspects, polysaccharide derivatives and / or underivatized forms thereof can be used as additives (part c), while in some aspects, polysaccharide derivatives and / or underivatized forms thereof (eg, β-1,4-glucan [cellulose]) are not used as additives.

[0119] The caustic solution herein can include one, two, three, or more different α-glucan derivatives herein (e.g., different in DPw, α-1,3 bond percentage, substituents, and / or DoS). In some aspects, the caustic solution does not include an α-glucan derivative herein, such as an ether or ester.

[0120] For example, any of the aforementioned polysaccharide derivatives (e.g., α-glucan derivatives) can be used as an additive in the solid compositions of the present disclosure. In some aspects where the additive is an α-glucan derivative, its α-glucan portion (i.e., as it exists prior to derivatization) can have the same (or similar, e.g., ±1%, 2%, or 3%) bond and molecular weight profile as the non-derivatized α-glucan component.

[0121] The caustic solvent of the present disclosure can typically dissolve the aqueous insoluble α-glucan and / or its derivatives of the part (b) of the caustic solution herein. In some aspects, the caustic solvent is aqueous. For example, the aqueous caustic solvent can include an alkaline hydroxide. The alkaline hydroxide can include at least one metal hydroxide (e.g., NaOH, KOH, LiOH) or an organic hydroxide (e.g., tetraethylammonium hydroxide). The aqueous caustic solvent can be as disclosed in, for example, International Patent Application Publication No. WO2015 / 200612 or WO2015 / 200590, or U.S. Patent Application Publication No. 2017 / 0208823 or 2017 / 0204203, each of which is incorporated herein by reference. Typically, the aqueous insoluble α-glucan and / or its derivatives of the part (b) of the caustic solution herein are not dispersed in the caustic solvent, or are otherwise insoluble in the solvent. One or more agents that make the solvent herein a harsh solvent (eg, NaOH) should not be considered an additive of the present disclosure (section [c]).

[0122] In some aspects, the aqueous caustic solvent comprises one or more alkaline hydroxides dissolved in water. For example, the concentration of the one or more alkaline hydroxides can be about, or at least about 3wt%, 4wt%, 5wt%, 6wt%, 7wt%, 8wt%, 9wt%, 10wt%, 11wt%, 12wt%, 13wt%, 14wt%, 15wt%, 3-15wt%, 3-12wt%, 3-10wt%, 3-8wt%, 3-7wt%, 3-6wt%, 3-5wt%, 3-4.5wt%, 4-15wt%, 4-12wt%, 4-10wt%, 4-8wt%, 4-7wt%, 4-6wt%, 4-5wt%, or 4-4.5wt%.

[0123] The pH of the caustic solution and / or caustic solvent thereof herein can be, for example, about, or at least about 10.5, 10.75, 11.0, 11.5, 12.0, 12.5, 13.0, 10.5-13.0, 10.5-12.5, 10.75-13.0, 10.75-12.5, 11.0-13.0, 11.0-12.5, 11.5-13.0, 11.5-12.5, 12.0-13.0, 12.0-12.5, or 12.5-13.0. The temperature of the caustic solution herein can be, for example, about, or at least about 1°C, 5°C, 10°C, 15°C, 20°C, 25°C, 30°C, 35°C, 40°C, 45°C, 50°C, 60°C, 70°C, 80°C, 90°C, 100°C, 110°C, 1°C-70°C, 1°C-60°C, 1°C-50°C, 1°C-45°C, 1°C-40°C, 1°C-35°C, 1°C-30°C, 1°C-25°C, 1°C-20°C, 15°C-70°C, ℃, 15℃-60℃, 15℃-50℃, 15℃-45℃, 15℃-40℃, 15℃-35℃, 15℃-30℃, 15℃-25℃, 15℃-20℃, 20℃-70℃, 20℃-60℃, 20℃-50℃, 20℃-45℃, 20℃-40℃, 20℃-35℃, 20℃-30℃, 20℃-25℃, 5℃-30℃, 10℃-30℃, 5℃-25℃ or 10℃-25℃.

[0124] The concentration of α-glucan and / or α-glucan derivative in the caustic solution herein can be, for example, about, or at least about 1 wt%, 2 wt%, 3 wt%, 4 wt%, 5 wt%, 6 wt%, 7 wt%, 8 wt%, 9 wt%, 10 wt%, 11 wt%, 12 wt%, 13 wt%, 14 wt%, 15 wt%, 16 wt%, 17 wt%, 18 wt%, 19 wt%, 20 wt%, 21 wt%, 22 wt%, 23 wt%, 24 wt%, 25 wt%, t%, 5-20wt%, 5-17.5wt%, 5-15wt%, 5-12.5wt%, 5-10wt%, 7.5-20wt%, 7.5-17.5wt%, 7.5-15wt%, 7.5-12.5wt%, 7.5-10wt%, 10-20wt%, 10-17.5wt%, 10-15wt%, 10-12.5wt%, 12.5-20wt%, 12.5-17.5wt%, or 12.5-15wt%.

[0125] The compositions disclosed herein, such as caustic solutions or any other compositions (e.g., fibers, fibrids, composites, or films / coatings) may contain from about 0.1 wt% to about 200 wt% of one or more additives, wherein the wt% is based on (relative to) the weight of the α-glucan and / or α-glucan derivative (part b) in the caustic solution or composition. In some aspects, the composition comprises about 0.05 wt%, 0.1 wt%, 0.5 wt%, 0.75 wt%, 0.8 wt%, 1.2 wt%, 2.4 wt%, 3.6 wt%, 4.7 wt%, 5.9 wt%, 6.8 wt%, 7.9 wt%, 8.1 wt%, 9.1 wt%, 10.2 wt%, 11.3 wt%, 12.4 wt%, 13.5 wt%, 1 1wt%, 2wt%, 3wt%, 4wt%, 5wt%, 6wt%, 7wt%, 8wt%, 9wt%, 10wt%, 11wt%, 12wt%, 13wt%, 14wt%, 15wt%, 16wt%, 17wt%, 18wt%, 19wt% , 20wt%, 25wt%, 30wt%, 35wt%, 40wt%, 45wt%, 50wt%, 75wt%, 100wt%, 125wt%, 150wt%, 175wt%, 200wt%, 1-200wt%, 1-175wt%, 1-1 50wt%, 1-125wt%, 25-200wt%, 25-175wt%, 25-150wt%, 25-125wt%, 50-200wt%, 50-175wt%, 50-150wt%, 50-125wt%, 75-200wt% , 75-175wt%, 75-150wt%, 75-125wt%, 100-200wt%, 100-175wt%, 100-150wt%, 100-125wt%, 0.1-50wt%, 1-30wt%, 1-25wt%, 1-20 wt%, 1-15wt%, 1-10wt%, 3-30wt%, 3-25wt%, 3-20wt%, 3-15wt%, 3-10wt%, 10-30wt%, 10-25wt%, 10-20wt%, 10-15wt%, 3-7wt%, 4 -6wt%, 8-12wt%, 9-11wt%, 22-28wt%, 23-27wt%, 0.05-1wt%, 0.05-0.75wt%, 0.05-0.5wt%, 0.05-0.25wt%, 0.1-1wt%, 0.1-0.75 wt%, 0.1-0.5wt%, 0.1-0.25wt%, 0.25-1wt%, 0.25-0.75wt%, 0.25-0.5wt%, 0.05-50wt%, 0.05-25wt%, 0.05-20wt%, 0.05-15wt %, 0.05-10wt%, 0.1-50wt%, 0.1-25wt%, 0.1-20wt%, 0.1-15wt%, 0.1-10wt%, 0.5-50wt%, 0.5-25wt%, 0.5-20wt%, 0.5-15wt%, 0.5-10wt%, 1-50wt%, 1-25wt%, 1-20wt%, 1-15wt%, 1-10wt%, 2.5-50wt%, 2.5-25wt%, 2.5-20wt%, 2.5-15wt%, 2.5-10wt%, 5-50wt%, 5-25wt%, 5-20wt%, 5-15wt%, or 5-10wt% of one or more additives, wherein the wt% is based on the weight of the one or more insoluble alpha-glucans in the composition.

[0126] For example, when all components of the caustic solution (at least the caustic solvent, α-glucan and / or α-glucan derivative, and additives) are combined, the amount of time the caustic solution may have been present (i.e., aged) may be about, or at least about, 0.25, 0.5, 0.75, 1, 1.25, 1.5, 2, 2.5, 3, 4, 5, 6, 7, 8, 9, 10, 20, 30, 40, 50, 75, 100, 150, 200, 0.5-3, 0.5-2.5, 0.5-2, 0.5-1.5, 0.5-1.25, 0.75-3, 0.75-2.5, 0.75-2, 0.75-1.5, or 0.75-1.25 days.

[0127] In some aspects, the caustic solution can have an elastic modulus (G') of about, or at least about 4, 5, 6, 8, 10, 20, 30, 40, 50, 60, 70, 80, 90, 100, 110, 120, 4-120, 4-110, 4-100, 4-90, 10-120, 10-110, 10-100, 10-90, 50-120, 50-110, 50-100, 50-90, 70-120, 70-110, 70-100, or 70-90 Pascals (Pa). In some aspects, the caustic solution can have a viscous modulus (G") of about, or at least about 35, 40, 50, 75, 100, 125, 150, 175, 200, 35-200, 35-175, 35-150, 40-200, 40-175, 40-150, 100-200, 100-175, 100-150, 125-200, 125-175, or 125-150 Pascals (Pa). The elastic modulus (G') and / or viscous modulus (G") herein can be measured according to the following examples (e.g., wherein each condition / parameter is within 5%, 10%, or 15% of the relevant condition / parameter disclosed in the examples).

[0128] In some aspects, the additives herein, such as part (c) for caustic solutions or any other composition (e.g., fibers, fibrids, composites, films / coatings, or powders) used herein, can comprise or consist of one or more crosslinking agents. Examples of crosslinking agents herein include phosphorus oxychloride (POCl3), polyphosphates, sodium trimetaphosphate (STMP), boron-containing compounds (e.g., boric acid, diborates, tetraborates such as tetraborate decahydrate, pentaborates, polymeric compounds such as alkali metal borates), polyvalent metals (e.g., titanium-containing compounds such as ammonium titanium lactate, titanium triethanolamine, titanium acetylacetonate, or titanium polyhydroxy complexes; zirconium-containing compounds such as zirconium lactate, zirconium carbonate, zirconium acetylacetonate, zirconium triethanolamine, zirconium diisopropyl lactate, or zirconium polyhydroxy complexes), glyoxal, glutaraldehyde, acetaldehyde, polyphenols, divinyl sulfone, epichlorohydrin, polyamide-epichlorohydrin (PAE), di- or polycarboxylic acids (e.g., citric acid, malic acid, tartaric acid, succinic acid, glutaric acid, adipic acid), Dichloroacetic acid, polyamines, 1,2,7,8-diepoxyoctane, diethylene glycol dimethyl ether (diglyme), diglycidyl ethers (e.g., diglycidyl ethers themselves, ethylene glycol diglycidyl ether [EGDGE], 1,4-butanediol diglycidyl ether [BDGE], polyethylene glycol diglycidyl ether [PEGDE, such as PEG2000DGE], bisphenol A diglycidyl ether [BADGE]), and triglycidyl ethers (e.g., trimethylolpropane triglycidyl ether). Still other examples of suitable crosslinking agents are described in U.S. Pat. Nos. 4,462,917, 4,464,270, 4,477,360, or 4,799,550, or U.S. Patent Application Publication No. 2008 / 0112907, each of which is incorporated herein by reference. In some aspects, the crosslinking agent is not a boron-containing compound (e.g., as described above). The cross-linking agent herein is typically soluble in a caustic solvent and acts to cross-link the alpha-glucan and / or alpha-glucan derivative molecules that are also dissolved in the caustic solvent. This cross-linking is typically covalent; that is, the alpha-glucan molecules and / or alpha-glucan derivative molecules are chemically cross-linked to each other (via intermolecular cross-linking). Therefore, in some aspects, the caustic solution can be characterized as comprising cross-linked alpha-glucan and / or cross-linked alpha-glucan derivatives, wherein any cross-linking agent as disclosed in the present invention is optionally used to prepare this cross-linked material. In some aspects, the alpha-glucan and / or alpha-glucan derivative are cross-linked before it enters a caustic solvent to produce the caustic solution herein (optionally using a cross-linking agent as disclosed in the present invention). Optionally, in the aspect of the cross-linking agent or cross-linked alpha-glucan and / or alpha-glucan derivatives included herein, there are no other additives or less than 0.1wt% of other additives.

[0129] The concentration of the one or more cross-linking agents in the caustic solution herein can be, for example, about, at least about, or less than about 0.005 wt%, 0.01 wt%, 0.025 wt%, 0.05 wt%, 0.1 wt%, 0.25 wt%, 0.5 wt%, 0.75 wt%, 1.0 wt%, 1.25 wt%, 1.5 wt%, 2.0 wt%, 3.0 wt%, 4.0 wt%, 5.0 wt%, 7.5 wt%, 10 wt%, 0.005-0.25 wt%, 0.005-0.20 wt%, 0.005-0.15 wt%, 0.005-0.10 wt%, 0.005-0.05 wt%, 0.005-0.06 wt%, 0.005-0.08 wt%, 0.005-0.16 wt%, 0.005-0.28 wt%, 0.005-0.30 wt%, 0.005-0.35 wt%, 0.005-0.36 wt%, 0.005-0.37 wt%, 0.005-0.38 wt%, 0.005-0.39 wt%, 0.005-0.40 wt%, 0.005 .005-0.01wt%, 0.01-0.25wt%, 0.01-0.20wt%, 0.01-0.15wt%, 0.01-0.10wt%, 0.01-0.05wt%, 0.1-3.0wt%, 0.1-2.0wt%, 0.1-1.5wt%, 0.1-1.25wt%, 0.1-1.0wt%, 0.5-3.0wt%, 0.5-2.0wt%, 0.5-1.5wt%, 0.5-1.25wt%, or 0.5-1.0wt%, wherein the wt% is based on (relative to) the weight of the α-glucan and / or α-glucan derivative (part b) in the caustic solution. Such concentrations can typically be characterized as initial concentrations (eg, concentrations calculated based on the amount of cross-linking agent added) because as the α-glucan and / or α-glucan derivative is cross-linked by the cross-linking agent, the concentration of free cross-linking agent typically decreases.

[0130] The cross-linked α-glucan and / or cross-linked α-glucan derivatives disclosed herein are typically soluble in the caustic solvents herein, while typically insoluble in non-caustic aqueous solvents (e.g., water alone). All or most (e.g., at least about 70%, 75%, 80%, 85%, 90%, or 95% complete) cross-linking herein (e.g., as measured by the maximum reduction in free cross-linker concentration) typically occurs in a caustic solution, which is then formed into a desired shape / product (e.g., fiber, fibrid, film / coating / layer, composite material).

[0131] An additive herein, such as part (c) or any other composition (e.g., fiber, fibrid, composite, film / coating, or powder) used in the caustic solution herein, may alternatively be referred to as "another ingredient" or "another component," for example (wherein the first, or other ingredient / component is one or more α-glucan or α-glucan derivative compounds). Except for aspects where the additive is a cross-linking agent, the additive typically does not chemically react with the α-glucan or α-glucan derivative, and therefore does not chemically modify or derivatize it in any manner that produces a compound different from the α-glucan or α-glucan derivative that existed before the addition of the additive (e.g., such additive does not serve to replace any hydrogen of the hydroxyl group of the glucose monomer unit of the α-glucan or α-glucan derivative; e.g., such additive does not change the molecular formula of the α-glucan or α-glucan derivative). In some aspects, there may be one, two, three, four, or more additives. The additive may be soluble or insoluble in the caustic solution. The additive may be soluble or insoluble in the non-harsh aqueous solvent (eg, water alone).

[0132] The additive herein can be any compound of the present disclosure. The disclosure of the additive herein typically relates to its state of existence before being used to prepare the composition herein (i.e., the state in which the additive is provided before mixing with other components herein). In some aspects, the additive comprises or consists of: a non-aqueous liquid and / or a hydrophobic or non-polar liquid or composition. The non-aqueous liquid can be, for example, polar or non-polar (non-polar / apolar). In some aspects, the additive can comprise or consist of a solid material; such an additive can be optionally in an aqueous liquid or a non-aqueous liquid. The additive can have, for example, a neutral, negative (anionic), or positive (cationic) charge; that is, the additive can be charged. Examples of charged additives include charged polysaccharides and charged polysaccharide derivatives (e.g., polysaccharide ethers) (e.g., soluble or insoluble forms thereof), such as any as disclosed herein (e.g., with respect to α-glucans, wherein at least about 50% of the glycosidic bonds of the α-glucans are α-1,3 glycosidic bonds, and the α-glucans have a weight average degree of polymerization of at least 15). The additive can be any ingredient / component typically used in, for example, personal care products, pharmaceutical products, household care products, industrial products, ingestible products, films / coatings, composite materials, latexes / dispersions / emulsions, encapsulants, detergent compositions (e.g., fabric care, dish care), oral care, or builder compositions.As an example, the additive herein can be an oil, such as mineral oil, silicone oil (e.g., dimethicone / polydimethylsiloxane, hexamethyldisiloxane), paraffin oil, or plant / vegetable oil (e.g., linseed oil, soybean oil, palm oil, coconut oil, canola oil, corn oil, sunflower oil, grapeseed oil, cocoa butter, olive oil, rice bran oil, rapeseed oil, peanut oil, sesame oil, cottonseed oil, palm kernel oil); shortening (e.g., vegetable shortening) ; lipids; fats (e.g., lard, tallow, animal fats); glycerides (e.g., tri-, di- and / or mono-glycerides; e.g., caprylic / capric triglycerides); glycerol (or other polyols, such as low molecular weight polyols); fatty acids; fatty aldehydes, fatty alcohols, fatty acid esters (e.g., sorbitan oleate); fatty acid amides (e.g., ethylene bis(stearamide)); waxes (e.g., paraffin, carnauba wax); phospholipids; sterols; alkanes; olefins; petroleum jelly (i.e., petroleum jelly); jelly); grease; detergent; anionic detergent (e.g., lauryl sulfate, alkylbenzene sulfonate); cationic detergent; nonionic or zwitterionic detergent (e.g., polyoxyethylene-based detergents such as Tween or Triton [ethoxylate], glycoside-based detergents such as octylthioglucoside maltoside, CHAPS); or any epoxidized form of these; or any similar compound, such as disclosed in U.S. Patent Application Publication Nos. 2009 / 0093543 (e.g., Table 2 therein) or 2019 / 0144897, which are incorporated herein by reference. As examples, the additives herein can be sugar alcohols (e.g., mannitol, sorbitol, xylitol, lactitol, isomalt, maltitol, hydrogenated starch hydrolysate), polymer polyols (e.g., polyether polyols, polyester polyols, polyethylene glycol, polyvinyl alcohol), aprotic solvents (e.g., polar aprotic solvents such as acetone or propylene carbonate), protic solvents (e.g., isopropanol, ethanol, methanol), hardeners (e.g., active halogen compounds, vinyl sulfones, epoxy compounds), resins (typically uncured) (e.g., synthetic resins such as epoxy resins or acetal resins; natural resins such as plant resins [e.g., rosin], insect resins [e.g., shellac], or bitumin), or propylene glycol.By way of example only, the additive herein can be a fragrance / flavor (e.g., a hydrophobic aroma compound, or any as disclosed in U.S. Pat. No. 7,196,049, which is incorporated herein by reference), an ingestible product, food, beverage, a flavoring (e.g., any as disclosed in U.S. Pat. No. 7,022,352, which is incorporated herein by reference), a hydrophobic flavorant or nutrient (e.g., a vitamin, such as vitamin A, D, E, or K), or a dye (e.g., an oil-soluble dye, such as Sudan red). As an example, the additive herein can be polyurethane, polyvinyl acetate, polyacrylate, polylactic acid, polyvinylamine, polycarboxylate, a polysaccharide other than a water-insoluble α-glucan having at least 50% α-1,3 glycosidic bonds herein, a polysaccharide derivative (water-soluble or water-insoluble) herein (such as a derivative of a water-insoluble α-glucan having at least 50% α-1,3 glycosidic bonds as disclosed in the present invention (in some aspects, if the additive is an α-1,3-glucan derivative, the composition herein comprises containing non-derivatized water-insoluble α-1,3-glucan as another component, such as [b] part for caustic solution or products made therefrom) or any other polysaccharide derivative herein), gelatin, melamine, inorganic filler materials (e.g., carbon black, silicates such as sodium silicate, talc, chalk, clays such as bentonite, or carbonates such as calcium carbonate, calcium magnesium carbonate, sodium percarbonate, sodium carbonate, sodium bicarbonate, ammonium bicarbonate, barium carbonate, magnesium carbonate, potassium carbonate, or iron carbonate [II]), penetrants (e.g., 1,2-propylene glycol , triethylene glycol butyl ether, 2-pyrrolidone), biocides (e.g., metaborate, thiocyanate, sodium benzoate, benzisothiazoline-3-one), yellowing inhibitors (e.g., sodium hydroxymethyl sulfonate, sodium p-toluene sulfonate), ultraviolet absorbers (e.g., benzotriazole compounds), antioxidants (e.g., sterically hindered phenol compounds), waterproofing agents (e.g., ketone resins, anionic latex, glyoxal), or binders (e.g., polyvinyl alcohol, polyvinyl acetate, partially saponified polyvinyl acetate, silanol-modified polyvinyl alcohol, polyvinyl acetate, ... Amine, starch, corn dextrin, carboxymethyl cellulose, cellulose ether, hydroxyethyl cellulose, hydroxypropyl cellulose, ethyl hydroxyethyl cellulose, methyl cellulose, alginate, sodium alginate, xanthan gum, carrageenan, casein, soy protein, guar gum, styrene butadiene latex, styrene acrylate latex. In some aspects, the additive can be a bleaching agent (e.g., a chlorine-based bleaching agent such as sodium hypochlorite or chlorinated lime; a peroxide-based bleaching agent such as hydrogen peroxide, sodium percarbonate, peracetic acid, benzoyl peroxide, or potassium permanganate).In some aspects, the additive can be characterized / classified as follows: amphiphilic materials (e.g., surfactants such as lauryl sulfate; polymeric surfactants such as polyethylene glycol or polyvinyl alcohol; particles such as silica), water-insoluble small molecules (e.g., mineral oil; silicone oil; natural oils such as linseed oil, soybean oil, palm oil, or coconut oil), water-insoluble polymer molecules (e.g., polyacrylates, polyvinyl acetate, polylactic acid), water-miscible small molecules (e.g., protic solvents such as isopropanol, ethanol, or methanol; polar aprotic solvents such as acetone or propylene carbonate; low molecular weight polyols such as glycerol; sugar alcohols), or water-miscible polymeric molecules (e.g., polyols). In some aspects, the additive can be an alkyl ketene dimer (AKD), alkenyl succinic anhydride (e.g., octenyl succinic anhydride), an epoxide (e.g., epoxidized linseed oil or diepoxide), phenylethyl alcohol, undecanol, or tocopherol. In some aspects, the additive can be an elastomer. In some aspects, the additive can be rubber or any other diene-based elastomer. The example of rubber herein includes natural rubber (NR) (for example, NR latex) and synthetic rubber.The example of synthetic rubber herein includes synthetic polyisoprene, polybutadiene, styrene-butadiene copolymer, styrene-isoprene copolymer, butadiene-isoprene copolymer, styrene-butadiene-isoprene terpolymer, ethylene propylene diene monomer rubber, hydrogenated nitrile rubber, silicone rubber and chloroprene rubber, which are also examples of elastomers based on diene.In some respects, rubber is not based on diene, such as silicone rubber.In some respects, additive is not rubber.In some respects, additive includes wherein dissolved hydrophobic material (for example, any as disclosed herein, such as hydrophobic aromatics, flavorings, nutrients or dyes) oil or any other hydrophobic solvents herein.Additive herein is typically not only salt (salt ions) or buffer, such as Na. + , Cl - , NaCl, phosphate, tris, or any other salt / buffer, such as disclosed in U.S. Patent Application Publication Nos. 2014 / 179913, 2016 / 0304629, 2016 / 0311935, 2015 / 0239995, 2018 / 0230241, or 2018 / 0237816, which are incorporated herein by reference. For example, the additive may be any additive disclosed in U.S. Patent Application Publication No. 2019 / 0153674 (incorporated herein by reference).

[0133] In some aspects, the additive is a water-insoluble polysaccharide (e.g., any polysaccharide herein, such as cellulose), and remains undissolved throughout the methods of producing the solid composition herein (i.e., the insoluble polysaccharide does not dissolve in the selected caustic solution). In such aspects, the solid composition comprises the water-insoluble polysaccharide additive in a dispersed manner (i.e., the solid composition is a solid sol), rather than in a uniform manner, which would result if the water-insoluble polysaccharide were dissolved in the selected caustic solution.

[0134] In some aspects, the additive is hydrophobic (e.g., any of the above described as hydrophobic / apolar / non-polar). The hydrophobic additive is a liquid (e.g., at the temperatures disclosed herein, e.g., 10°C-60°C, 15°C-60°C, 20°C-60°C, 25°C-60°C, 30°C-60°C, 10°C-55°C, 15°C-55°C, 20°C-55°C, 25°C-55°C, 30°C-55°C, 10°C-50°C, 15°C-50°C, 20°C-50°C, 25°C-5 In some aspects, the hydrophobic additive is a solid (e.g., at a temperature disclosed herein) and is not soluble in an aqueous composition (e.g., caustic or non-caustic aqueous conditions herein). The solid hydrophobic additive can be, for example, a wax or grease. In some aspects, the solid hydrophobic additive has a melting point of about or at least about 45°C, 46°C, 48°C, 50°C, 52°C, 54°C, 56°C, 58°C, 60°C, 62°C, 64°C, 66°C, 68°C, 70°C, 75°C, 80°C, 85°C, 90°C, 95°C, 100°C, 45°C-70°C, 45°C-65°C, 50°C-70°C, or 50°C-65°C.

[0135] In some aspects, emulsion aids (emulsion stabilizers) can be used to prepare emulsions of liquid additives in caustic solvents. Examples of emulsion aids include surfactants (e.g., anionic surfactants, such as sodium lauryl sulfate) and polyelectrolytes (e.g., anionic polyelectrolytes). For example, the emulsion stabilizer herein can be included in the caustic solvent herein at about 0.001-0.01wt%, 0.004-0.006wt%, or 0.005wt%.

[0136] In some aspects, the caustic solution of the present disclosure can be in the form (shape) of filaments (dope filaments), films / coatings, or other three-dimensional materials (e.g., fibrids, composites). Such a form can exist, for example, as a caustic solution just before removing the caustic solvent therefrom to provide a solid material (e.g., fibers, films / coatings, fibrids, composites).

[0137] Some aspects of the present disclosure relate to a method of producing a caustic solution herein. Such a method may include, for example, mixing at least (i) an α-glucan and / or an α-glucan herein and (ii) an additive herein with a caustic solvent (mixing into a caustic solvent), wherein the α-glucan and / or its derivative is dissolved in the caustic solvent. In some aspects, the additive is dissolved in the caustic solvent, but in some other aspects remains undissolved (e.g., dispersed).

[0138] Some aspects of the present disclosure relate to a method for producing a solid composition. This method may include, for example: (a) providing a caustic solution herein, (b) causing the caustic solution to be in (shaped / cast / formed / extruded into) a desired form (e.g., a fiber, film / coating, fibrid, or composite material; for example, an extruded and / or stretched form, which may optionally be a fiber, film, or composite material), and (c) removing the caustic solvent from the caustic solution of step (b) to produce a solid composition comprising α-glucan or a derivative thereof and an additive. For example, a solid composition such as produced by step (c) may be in the form / shape of a fiber (e.g., filament), fibrid, extrudate, composite material, or film / coating (or any form such as a fiber or film made by extruding and / or stretching the caustic solution prior to step [c]). This method may be optionally characterized herein as a forming method or a shaping method. Some aspects herein relate to a composition / product comprising a solid composition produced by a method / process as disclosed herein.

[0139] In some aspects, the step (b) of placing the caustic solution in a desired form may include using a device having one or more orifices (e.g., holes, nozzles, or perforations) through which the caustic solution is transmitted (discharged / injected / pushed) through. Such processing may alternatively be characterized as extrusion. An example of a suitable device for performing step (b) in this manner is a spinneret. The shape of the caustic solution as processed by extrusion in step (b) may be, for example, a fiber (e.g., filament), a film, or a composite material; such a shape typically similarly characterizes the product produced in step (c). In some aspects, the fiber form (dope filaments / fibers) can be air drawn, for example using a spinneret, die, or similar device, optionally wherein (i) the air flow pressure is about, or up to about 10, 20, 30, 40, 50, 60, 70, 80, 90, 100, 10-100, 10-90, 10-80, 10-70, 20-100, 20-90, 20-80, 20-70, 30-100, 30-90, 30-80, 30-70, 40-100, 40-90, 40-80, or 40-70 mbar, (i or (i) an extrusion speed of about, at least about, or up to about 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 8-20, 8-15, 10-20, 10-15, 12-20, or 12-15 m / min, and / or (iii) a spinning speed of about, at least about, or up to about 10, 15, 20, 25, 30, 35, 40, 10-40, 10-35, 10-30, 15-40, 15-35, 15-30, 20-40, 20-35, or 20-30 m / min. The diameter (longest diameter) of one or more orifices of the device through which the caustic solution is transmitted can be, for example, about, at least about, or up to about 30, 40, 50, 60, 70, 80, 90, 30-90, 30-80, 30-70, 40-90, 40-80, 40-70, 50-90, 50-80, 50-70, or 55-65 microns. The orifice herein can have a cross section such as a circle, an ellipse, a square, or a rectangle. In some aspects, continuous stock solution filaments can be produced; such stock solution filaments do not undergo constant, repeated, or continuous breakage or other damage after they are transmitted from the orifice. The step (b) of making the caustic solution in the desired form can optionally further include stretching the caustic solution, such as after it has been extruded; stretching can optionally be used to reduce the diameter of the caustic solution such as the stock solution filaments extruded.In some aspects, the stock solution filaments have a diameter (longest diameter) that is about, or at least about 10%, 20%, 30%, 40%, 50%, 60%, 10%-60%, 10%-50%, 10%-40%, 10%-30%, 10%-20%, 20%-60%, 20%-50%, 20%-40%, or 20%-30% smaller than the diameter of an orifice (e.g., herein) used to extrude the stock solution used to make the stock solution filaments.

[0140] For example, the amount of caustic solvent removed in step (c) of the forming process can be about, or at least about 80 weight percent, 85 weight percent, 90 weight percent, 95 weight percent, 96 weight percent, 97 weight percent, 98 weight percent, 99 weight percent, 99.5 weight percent, 99.9 weight percent, 100 weight percent, 80-100 weight percent, 90-100 weight percent, 95-100 weight percent, or 98-100 weight percent of the caustic solvent present prior to performing step (c).

[0141] In some aspects of the forming method, the step (c) of removing the caustic solvent may include chemically or ionically modifying the caustic solvent (or caustic solution) so that the α-glucan or α-glucan derivative and additives (if they are dissolved in the caustic solvent) are no longer dissolved in the caustic solvent. This can be performed, for example, by a coagulation process and / or a neutralization process. It should be noted that when the caustic solution herein comprises cross-linked α-glucan or α-glucan derivative, coagulation or neutralization is not required to maintain the shape of the caustic solution form produced in step (b), but if desired, then this method can be applied to cross-linked materials (e.g., at least for the purpose of neutralization). In some aspects, typically those in which a cross-linking agent is not used, coagulation or neutralization is used to allow the form / shape produced in step (b) to be self-sustaining. To perform step (c), for example, the form / shape produced in step (b) can be contacted with (e.g., immersed / soaked in, sprayed with, or otherwise exposed to) a coagulation / neutralization medium (e.g., a liquid or aerosol form) for a suitable amount of time and / or at a temperature of less than about 60°C, 70°C, or 80°C (e.g., about room temperature [about 20°C-25°C] to about 80°C). The coagulation / neutralization medium typically comprises at least one non-solvent for α-glucan or α-glucan derivatives (and optionally additives), such as an alcohol (e.g., methanol, ethanol, propanol), water, an acid, or a mixture thereof. The acid for the coagulation / neutralization medium can be, for example, sulfuric acid, acetic acid, or citric acid. In some aspects, the coagulation / neutralization medium can comprise water and about 4-25wt% sulfuric acid and about 2-30wt% sodium sulfate. In some aspects, the coagulation / neutralization medium comprises little (≤0.1wt% or 0.05wt%) or no sulfate, such as zinc sulfate.

[0142] The solidified / neutralized form / shape after the washing step (c) can be optionally washed; for example, water or alcohol can be used for washing. If desired, washing can be performed until (washing liquid) reaches a neutral pH (e.g., pH 6-8 or about 7). The washing or post-washing step can optionally further include soaking the form / shape in a 1-10wt% (e.g., about 5wt%) plasticizer (e.g., glycerol or ethylene glycol) solution (e.g., based on water or alcohol) for a suitable period of time (e.g., at least 2, 3, or 4 minutes). If desired, the form / shape herein can be dried, such as by exposing it to a temperature of about 70°C-85°C for a suitable period of time (e.g., 10-20 minutes). In some aspects, the solidified form / shape after step (c) is not neutralized and / or washed.

[0143] In some aspects, solidification and / or neutralization can be performed as described in U.S. Patent Application Publication Nos. 2016 / 0177471, 2016 / 0333157, 2017 / 0283568, or 2015 / 0191550, or U.S. Patent Nos. 7,000,000 or 11,098,334, which are incorporated herein by reference, or as disclosed in the following examples (e.g., wherein each condition / parameter is performed within 5%, 10%, or 15% of the relevant condition / parameter disclosed in the examples).

[0144] In some aspects, step (c) may include air blowing caustic solution so that alpha-glucan or its alpha-glucan derivative and additive (if it is dissolved in caustic solvent) are no longer dissolved in caustic solvent. Such a method can be carried out, for example, as described in U.S. Patent Application Publication No. 2018 / 0282918, which is incorporated herein by reference. In some aspects, step (c) may include air drying caustic solution so that alpha-glucan or its alpha-glucan derivative and additive (if it is dissolved in caustic solvent) are no longer dissolved in caustic solvent. Optionally, the air drying form / shape after non-neutralization and / or washing step (c).

[0145] In some aspects, the shape formed after step (c) herein is stretched and / or heated (eg, about 100° C.-110° C.), or is not stretched or heated.

[0146] In some aspects of the forming method as depicted to produce fibrids, steps (b) and (c) are typically performed concomitantly with each other, in that the caustic solution herein is subjected to shear forces (step [b] of shape formation) while also being subjected to precipitation conditions that precipitate the α-glucan (e.g., as described above for step [c], such as with an acid or alcohol), so that fibrids comprising α-glucan (or α-glucan derivatives) and additives are formed. Such fibrids may alternatively be characterized as "hybrid fibrids." This method may be performed, for example, as described in U.S. Pat. No. 11118312, which is incorporated herein by reference, or as disclosed in the Examples below (e.g., wherein each condition / parameter is performed within 5%, 10%, or 15% of the relevant condition / parameter disclosed in the Examples). It is contemplated that in some aspects, one or more additives are encapsulated within the hybrid fibrids and / or embedded on the outer surface of the hybrid fibrids (and / or some other association mechanism) such that the one or more additives do not separate from the hybrid fibrids (or mostly do not separate from the hybrid fibrids) under non-caustic aqueous conditions; in some aspects, this may even be the case when the one or more additives are aqueous soluble (water soluble) under non-caustic conditions. It is contemplated that this additive retention behavior is equally applicable to other compositions herein, such as fibers (e.g., filaments), films / coatings, or composites. Some aspects of producing hybrid fibrids (or other hybrid compositions herein) involve adjusting / regulating / controlling the charge of the fibrids / product. Such aspects typically include using a suitable amount of a charged additive herein (e.g., a charged polysaccharide or a charged polysaccharide derivative) as part (c) of the caustic solution, and an α-glucan (uncharged / underivatized) herein as part (b) of the caustic solution to produce the fibrids or other compositions. This approach is superior to previous work in which the means of controlling product charge was by selecting a specifically charged α-glucan derivative as the sole fibrid / product component (i.e., no additives); this typically required providing an α-glucan derivative having a specific degree of substitution with a charged moiety (e.g., a charged organic group). Now, using the methods disclosed herein, fibrids / products having a preselected charge can be produced even when water-soluble charged additives are used (e.g., washing and / or other processing of the product in non-caustic aqueous conditions does not remove any or significant amounts of the water-soluble charged additive).

[0147] Some aspects herein relate to a method for producing a film / coating composition. This method may include, for example: (a) providing a formulation comprising at least (i) a caustic solvent as described herein, (ii) a water-insoluble α-glucan as described herein, and (iii) an additive (e.g., a hydrophobic additive) as described herein, wherein the α-glucan is dissolved in the caustic solvent; (b) contacting the formulation with a substrate; and (c) removing the caustic solvent from the formulation of step (b) to produce a film / coating composition comprising the α-glucan and the additive. The method may alternatively be characterized as a film or coating production method. If desired, the step of removing the caustic solvent may be performed as disclosed herein.

[0148] In some aspects of the film / coating production method, such as when the additive is a hydrophobic additive, the formulation is a dispersion. In aspects where a liquid hydrophobic additive is used, such a dispersion can be an emulsion (i.e., a liquid is dispersed but not dissolved in a caustic solvent); examples of suitable liquid hydrophobic additives are disclosed herein.

[0149] The substrate on which film or coating can be produced can be, for example, any substrate as disclosed herein. In some respects, for example, substrate is or comprises cellulose substrate, glass, leather, metal, polymer or fiber material based on non-cellulose, masonry, drywall, plaster, timber, building surface or food (for example, fruit or vegetable). The example based on non-cellulose polymer herein includes rubber (for example, natural rubber) or other elastomers based on diene, polyamide, polyolefin, polylactic acid, polyethylene terephthalate (PET), poly (trimethylene terephthalate) (PTT), aramid, polyethylene sulfide (PES), polyphenylene sulfide (PPS), polyimide (PI), polyethyleneimine (PEI), polyethylene naphthalate (PEN), polysulfone (PS), polyetheretherketone (PEEK), polyethylene, polypropylene, poly (cycloolefin), poly (cyclohexylene dimethylene terephthalate) and poly (trimethylene furandicarboxylate) (PTF). In some aspects, the cellulose substrate comprises about, or at least about 80%, 82.5%, 85%, 87.5%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, 99.5%, or 100% by weight of cellulose (typically in the form of cellulose fibers). Other components of the cellulose substrate may optionally include hemicellulose and / or lignin. The cellulose substrate is typically porous. In some aspects, the substrate may be a woven or nonwoven material (e.g., a woven or nonwoven fabric).

[0150] In some aspects, the film or coating can be a food casing. Food casings can be used, for example, for meat-based food products (e.g., meat products such as ground meat products, sausages, or processed meat products) or plant-based food products (e.g., meat substitutes, foods containing tofu, or foods containing beans).

[0151] In some aspects, the coating can be a seed coating or a fertilizer coating. For example, this coating can have any of the features of the film / coating herein (e.g., thickness, insoluble α-glucan content, additives). As with any solid composition / product disclosed herein, in some alternative aspects, the seed coating or fertilizer coating does not include the additives herein, wherein the additives will be present in the stock solution for producing the seed coating or fertilizer coating. The seed coating herein can be adapted for manufacture and / or use accordingly as disclosed in, for example, U.S. Patent Application Publication Nos. 2018 / 0325104, 2012 / 0220454, or 2012 / 0065060, each of which is incorporated herein by reference. The fertilizer coatings herein can be adapted for manufacture and / or use accordingly, for example, as disclosed in U.S. Patent Application Publication Nos. 2016 / 0229763, 2003 / 0033843, or 2009 / 0229330, each of which is incorporated herein by reference.

[0152] In some aspects of the film or coating production method, or in aspects of producing any of the other hybrid solid compositions herein (e.g., fibers, extrudates, fibrids, powders, or composites), the film or coating (or other hybrid solid composition) can be heated to a temperature of at least about 45°C (or to a temperature that melts the additive). In such aspects, the additive can be, for example, hydrophobic, and / or solid at 20°C-25°C. In some aspects, the heating can be to about, or at least about 45°C, 46°C, 48°C, 50°C, 52°C, 54°C, 56°C, 58°C, 60°C, 62°C, 64°C, 66°C, 68°C, 70°C, 75°C, 80°C, 85°C, 90°C, 95°C, 100°C, 45°C-70°C, 45°C-65°C, 50°C-70°C, or 50°C-65°C, or to about, or at least about the melting point temperature of the otherwise solid hydrophobic additives herein. Typically, the heating temperature can be maintained for a suitable length of time (e.g., ≥15, 30, 45, 60, 120, 240, or 360 seconds) to melt the additives in the film / coating or other hybrid solid composition (i.e., the melting occurs in situ in the composition). In some aspects, such heating and in situ melting of the additives can be used to heat seal the film / coating or other hybrid solid composition herein.

[0153] Some aspects of producing a solid composition may further include providing a powder (or other particulate form, such as granules).For example, a solid composition may be ground, or otherwise comminuted, into a powder, typically after it has been dried.

[0154] Some aspects of the present disclosure relate to a composition / product comprising a solid composition comprising at least α-glucan and / or a derivative thereof, wherein (i) the α-glucan and / or its derivative is cross-linked, and / or (ii) the composition further comprises an additive (e.g., water-insoluble or water-soluble) that is not chemically linked to the α-glucan or its derivative, wherein at least about 50% of the glycosidic bonds of the α-glucan are α-1,3 glycosidic bonds, and the weight average degree of polymerization of the α-glucan is at least 15. Examples of solid compositions (hybrid solid compositions) herein include fibers (e.g., filaments), fibrids (hybrid fibrids), extrudates, composites, powders (dried powders), or films / coatings. The solid composition can be produced, for example, as disclosed herein, and / or have any of the features herein for producing one or more components of the solid composition. The solid compositions herein are typically not produced in a manner that does not include the use of a caustic solution herein; for example, the solid compositions herein are typically not produced by a process that includes dispersing an insoluble α-glucan or an insoluble derivative thereof in a non-caustic aqueous medium, followed by shape formation and removal of water (drying) without having processed the α-glucan or derivative thereof in a caustic solution.

[0155] A solid composition / product as disclosed herein can include, for example, at least about 0.5 wt% of at least one additive herein and up to about 99.5 wt% of at least one water-insoluble α-glucan (or a water-insoluble derivative thereof, if present, which is different from the one or more additives). In some aspects, the solid composition / product includes (i) about or at least about 0.01 wt%, 0.025 wt%, 0.05 wt%, 0.1 wt%, 0.25 wt%, 0.5 wt%, 1 wt%, 2 wt%, 3 wt%, 4 wt%, 5 wt%, 6 wt%, 7 wt%, 8 wt%, 9 wt%, 10 wt%, 11 wt%, 12 wt%, 13 wt%, 14 wt%, 15 wt%, 16 wt%, 17 wt%, 18 wt%, 19 wt%, 20 wt%, 21 wt%, 22 wt%, 23 wt%, 24 wt%, 25 wt%, 26 wt%, 27 wt%, 28 wt%, 29 wt%, 30 wt%, 31 wt%, 32 wt%, 33 wt%, 34 wt%, 35 wt%, 36 wt%, 37 wt%, 38 wt%, 39 wt%, 40 wt%, 41 wt%, 42 wt%, 43 wt%, 44 wt%, 45 wt%, 46 wt%, 47 wt%, 48 wt%, 49 wt%, 50 wt%, 51 wt%, 52 wt%, 53 wt%, 54 wt%, 55 wt%, 56 wt%, 57 wt%, 58 wt%, 59 wt%, 60 wt%, 61 wt%, 62 wt%, 63 8wt%, 29wt%, 30wt%, 31wt%, 32wt%, 33wt%, 34wt%, 35wt%, 36wt%, 37wt%, 38wt%, 39wt%, 40wt%, 41wt%, 42wt%, 43wt%, 44wt%, 45wt%, 46wt% , 47wt%, 48wt%, 49wt%, 50wt%, 51wt%, 52wt%, 53wt%, 55wt%, 56wt%, 57wt%, 58wt%, 59wt%, 60wt%, 61wt%, 62wt%, 63wt%, 64wt%, 65wt%, 66wt %, 67wt%, 68wt%, 69wt%, 70wt%, 71wt%, 72wt%, 73wt%, 74wt%, 75wt%, 76wt%, 77wt%, 78wt%, 79wt%, 80wt%, 81wt%, 82wt%, 83wt%, 84wt%, 85 wt%, 86wt%, 87wt%, 88wt%, 89wt%, 90wt%, 91wt%, 92wt%, 93wt%, 94wt%, 95wt%, 96wt%, 97wt%, 98wt%, 99wt%, 99.5wt%, 0.01-50wt%, 0.01-4 0wt%, 0.01-30wt%, 0.01-20wt%, 0.01-10wt%, 0.01-5wt%, 0.1-50wt%, 0.1-40wt%, 0.1-30wt%, 0.1-20wt%, 0.1-10wt%, 0.1-5wt%, 0.5-5 0wt%, 0.5-40wt%, 0.5-30wt%, 0.5-20wt%, 0.5-10wt%, 0.5-5wt%, 1-50wt%, 1-40wt%, 1-30wt%, 1-20wt%, 1-10wt%, 1-5wt%, 2.5-50wt%, 2.%, 5-40 wt%, 02.5-30 wt%, 2.5-20 wt%, 2.5-10 wt%, 5-50 wt%, 5-40 wt%, 5-30 wt%, 5-20 wt%, or 5-10 wt% of at least one additive, and (ii) about or up to about 99.99 wt%, 99.975 wt%, 99.95 wt%, 99.9 wt%, 99.75 wt%, 99.5 wt%, 99 wt%, 98 wt%, 97 wt%, 96 wt%, 95 wt%, 94 wt%, 93 wt%, 92 wt%, 91 wt%, 90 wt%, 89 wt%, 88 wt%, 87 wt%, 86 wt% , 85wt%, 84wt%, 83wt%, 82wt%, 81wt%, 80wt%, 79wt%, 78wt%, 77wt%, 76wt %, 75wt%, 74wt%, 73wt%, 72wt%, 71wt%, 70wt%, 69wt%, 68wt%, 67wt%, 66w t%, 65wt%, 64wt%, 63wt%, 62wt%, 61wt%, 60wt%, 59wt%, 58wt%, 57wt%, 56 wt%, 55wt%, 54wt%, 53wt%, 52wt%, 51wt%, 50wt%, 49wt%, 48wt%, 47wt%, 4 6wt%, 45wt%, 44wt%, 43wt%, 42wt%, 41wt%, 40wt%, 39wt%, 38wt%, 37wt%, 36wt%, 35wt%, 34wt%, 33wt%, 32wt%, 31wt%, 30wt%, 29wt%, 28wt%, 27wt% , 26wt%, 25wt%, 24wt%, 23wt%, 22wt%, 21wt%, 20wt%, 19wt%, 18wt%, 17wt %, 16wt%, 15wt%, 14wt%, 13wt%, 12wt%, 11wt%, 10wt%, 9wt%, 8wt%, 7wt%, 6wt%, 5wt%, 4wt%, 3wt%, 2wt%, 1wt%, 0.5wt%, 50-99.99wt%, 60-99.99wt %, 70-99.99wt%, 80-99.99wt%, 90-99.99wt%, 95-99.99wt%, 50-99.9wt %, 60-99.9wt%, 70-99.9wt%, 80-99.9wt%, 90-99.9wt%, 95-99.9wt%, 50 -99.5wt%, 60-99.5wt%, 70-99.5wt%, 80-99.5wt%, 90-99.5wt%, 95-99.5wt%, 50-99wt%, 60-99wt%, 70-99,80-99wt%, 90-99wt%, 95-99wt%, 50-97.5wt%, 60-97.5wt%, 70-97.5wt%, 80-97.5wt%, 90-97.5wt%, 95-97.5wt%, 50-95wt%, 60-95wt%, 70-95wt%, 80-95wt%, or 90-95wt% of at least one water-insoluble α-glucan (or a water-insoluble derivative thereof).

[0156] In some aspects, the solid composition / product is biodegradable. After 15, 30, 45, 60, 75, or 90 days of testing, for example, such biodegradability can be determined as about, at least about, or at most about 5%, 10%, 15%, 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 5%-60%, 5%-80%, 5%-60%, 5%-80%, 5%-60%, 5%-80%, 5%-60%, 5%-80%, 5%-80%, 5%-80%, 5%-80%, 5%-80%, 5%-80%, 5%-80%, 5%-80%, 5%-80%, 5%-80%, 5%-80%, 5%-80%, 5%-6 ...10%, 15%, 15%, 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 5%-60%, 5%-80%, 5%-80%, 5%-80%, 5%-80%, 5%-80%, 5%-80%, 5%-80%, 5%-80%, 5%-80%, 5%-80%, 5%-80%, 5%-80%, 5%-80%, -90%, 40%-70%, 50%-70%, 60%-70%, 40%-75%, 50%-75%, 60%-75%, 70%-75%, 40%-80%, 50%-80%, 60%-80%, 70%-80%, 40%-85%, 50%-85%, 60%-85%, 70%-85%, 40%-90%, 50%-90%, 60%-90%, or 70%-90%, or any value between 5% and 90%.

[0157] The solid compositions / products herein are typically non-porous (e.g., pores cannot be detected on the micron or nanometer scale, either on the surface of the product or by cross-sectional analysis). However, in some aspects, the solid composition / product may be porous (e.g., containing discontinuous pores and / or continuous pores). The solid porous composition / product may be, for example, a foam, an aerogel, or a sponge, and / or nanoporous (e.g., mesoporous), microporous, or macroporous. The pores may be provided, for example, by introducing a gas (e.g., air, nitrogen, carbon dioxide) into a caustic solution during the forming step (b), and then performing step (c), such as by solidification / neutralization. However, in some aspects, the pores may be provided, for example, by introducing a gas (e.g., carbon dioxide) into a caustic solution while performing step (c) including neutralization; in this sense, the forming step (b) may be extended to step (c), to the extent that pore formation may optionally be considered as part of the shape forming process. Gas formation during neutralization in step (c) herein can be accomplished by including an additive that reacts to form a product including a gas (e.g., carbon dioxide) when neutralized in a neutralized environment (e.g., during stock neutralization), such as with an acid. An example of such an additive is a carbonate (e.g., calcium carbonate) herein; such an additive can be present in the stock solution, for example, at about 0.1-10 wt % (e.g., any wt % within the range as disclosed herein). In some aspects, pores (such as those of a sponge) can be provided by including more than one water-soluble salt (provided in step [a]) in a caustic solution, and after step (c), dissolving the salts in the solid composition out with water or an aqueous solution.

[0158] As disclosed herein, the composition / product comprising at least one solid composition herein can be, for example, an aqueous composition / product (e.g., a dispersion such as a colloidal dispersion, a mixture) or a dried composition / product. In some aspects, the composition / product herein can comprise about, at least about, or less than about 0.001 wt% or w / v%, 0.0025 wt% or w / v%, 0.005 wt% or w / v%, 0.0075 wt% or w / v%, 0.01 wt% or w / v%, 0.025 wt% or w / v%, 0.05 wt% or w / v%, 0.1 wt% or w / v%, 0.2 wt% or w / v%, 0.25 wt% or w / v%, 0.3 wt% or w / v%, 0.4 wt% or w / v%, 0.5 wt% or w / v%, 0.6 wt% or w / v%, 0.7 wt% or w / v%, 0.8 wt% or w / v%, 0.9 wt% or w / v%, 10 wt% or w / v%, 11 wt% or w / v%, 12 wt% or w / v%, 13 wt% or w / v%, 14 wt% or w / v%, 15 wt% or w / v%, 16 wt% or w / v%, 17 wt% or w / v%, 18 wt% or w / v%, 19 wt% or w / v%, 20 wt% or w / v%, 21 wt% or w / v%, 22 wt% or w / v%, 23 wt% or w / v%, 24 wt% or w / v%, 25 wt% or w / v%, 26 wt% or w / v%, 27 wt% or w / v%, 28 wt% or w / v%, 29 wt% or w / v % or w / v%, 0.8wt% or w / v%, 0.9wt% or w / v%, 1.0wt% or w / v%, 1.2wt% or w / v%, 1.25wt% or w / v%, 1.4wt% or w / v%, 1.5wt% or w / v%, 1.6wt% or w / v%, 1.75wt% or w / v%, 1.8wt% or w / v%, 2.0wt% or w / v%, 2.25wt% or w / v%, 2.5wt% or w / v%, 3.0wt% or w / v%, 3.5wt% or w / v%, 4.0wt% or w / v%, 4.5wt% or w / v%, 5wt% or w / v%, 6wt% or w / v%, 7wt% or w / v%, 8wt% or w / v%, 9wt% or w / v%, 10wt% or w / v%, 11wt% or w / v%, 12wt% or w / v%, 13wt% or w / v%, 14wt% or w / v%, 15wt% or w / v%, 16wt% or w / v%, 17wt% or w / v%, 18wt% or w / v%, 19wt% or w / v%, 20wt% or w / v%, 21wt% or w / v%, 22wt% or w / v%, 23wt% or w / v%, 24wt% or w / v%, 25 %, 7wt% or w / v%, 8wt% or w / v%, 9wt% or w / v%, 10wt% or w / v%, 11wt% or w / v%, 12wt% or w / v%, 13wt% or w / v%, 14wt% or w / v%, 15wt% or w / v%, 16wt% or w / v%, 17wt% or w / v%, 18wt% or w / v%, 19wt% or w / v%, 20wt% or w / v%, 21wt% or w / v%, 22wt% or w / v%, 23wt% or w / v%, 24wt% or w / v%, 25wt% or w / v%, 26wt% or w / v%, 27wt% or w / v%, 28wt% or w / v%, 29wt% or w / v%, 30wt% or w / v%, 31wt% or w / v%, 32wt% or w / v%, 33wt% or w / v%, 34wt% or w / v%, 35wt% or w / v%, 36wt% or w / v%, 37wt% or w / v%, 38wt% or w / v%, 39wt% or w / v%, 40wt% or w / v%, 41wt% or w / v%, 42wt% or w / v%, 43wt% or w / v%, 44wt% or w / v%, 45wt% or w / v%, 46wt% or w / v%, 47wt% or w / v%, 48wt% or w / v%,49wt% or w / v%, 50wt% or w / v%, 51wt% or w / v%, 52wt% or w / v%, 53wt% or w / v%, 55wt% or w / v%, 56wt% or w / v%, 57wt% or w / v%, 58wt% or w / v%, 59wt% or w / v%, 60wt% or w / v%, 61wt% or w / v%, 62wt% or w / v%, 63wt% or w / v%, 64wt% or w / v%, 65wt% or w / v%, 66wt% or w / v%, 67wt% or w / v%, 68wt% or w / v%, 69wt% or w / v%, 70wt% or w / v%, 71wt% or w / v%, 72wt% or w / v%, 73wt% or w / v%, 74wt% or w / v%, 75wt% or w / v%, 76wt% or w / v%, 77wt% or w / v%, 78wt% or w / v%, 79wt% or w / v%, 80wt% or w / v%, 81wt% or w / v%, 82wt% or w / v%, 83wt% or w / v%, 84wt% or w / v%, 85wt% or w / v%, 86wt% or w / v%, 87wt% or w / v%, 88wt% or w / v%, 89wt% or w / v%, 90wt% or w / v%, 91wt% or w / v%, 92wt% or w / v%, 93wt% or w / v%, 94wt% or w / v%, 95wt% or w / v%, 96wt% or w / v%, 97wt% or w / v%, 98wt% or w / v%, 99wt% or w / v%, 100wt% or w / v%, 101wt% or w / v%, 102wt% or w / v%, 103wt% or w / v%, 104wt% or w / v%, 105 6wt% or w / v%, 77wt% or w / v%, 78wt% or w / v%, 79wt% or w / v%, 80wt% or w / v%, 81wt% or w / v%, 82wt% or w / v%, 83wt% or w / v%, 84wt% or w / v%, 85wt% or w / v%, 86wt% or w / v%, 87wt% or w / v%, 88wt% or w / v%, 89wt% or w / v%, 90wt% or w / v%, 91wt% or w / v%, 92wt% or w / v%, 93wt% or w / v%, 94wt% or w / v%, 95wt% or w / v%, 96wt% or w / v%, 97wt% or w / v%, 98wt% or w / v%, 99wt% or w / v%, 100wt% or w / v%, 101wt% or w / v%, 102wt% or w / v%, 103wt% or w / v%, 104wt% or w / v%, 105wt% or w / v%, 106wt% or w / v%, 107wt% or w / v%, 108wt% or w / v%, 109wt% or w / v%, 110 The solid compositions herein of 9wt% or w / v%, 90wt% or w / v%, 91wt% or w / v%, 92wt% or w / v%, 93wt% or w / v%, 94wt% or w / v%, 95wt% or w / v%, 96wt% or w / v%, 97wt% or w / v%, 98wt% or w / v%, 99wt% or w / v%, or 99.5wt% or w / v% can be used herein. ... The solvent of the non-caustic aqueous medium is typically water, or may contain, for example, about or at least about 10 wt%, 20 wt%, 30 wt%, 40 wt%, 50 wt%, 60 wt%, 70 wt%, 80 wt%, 90 wt%, 95, 98 wt%, or 99 wt% water.

[0159] The temperature of the aqueous medium in which the compositions herein, such as solid compositions, may be contained can be, for example, about, at least about, or up to about 0°C, 1°C, 5°C, 10°C, 15°C, 20°C, 25°C, 30°C, 35°C, 37°C, 40°C, 42°C, 45°C, 50°C, 55°C, 60°C, 65°C, 70°C, 75°C, 80°C, 85°C, 90°C, 95°C, 100°C, 105°C, 110°C, 115°C, 120°C, 125°C, 130°C, 10°C-30°C, 10°C-25°C, 15°C-30°C, 15°C-25°C, 20°C-40°C, 20°C-35°C, 20°C-2 5°C, 25°C-30°C, 30°C-50°C, 30°C-45°C, 30°C-40°C, 30°C-35°C, 35°C-40°C, 35°C-50°C, 40°C-45°C, 50°C-60°C, 5°C-50°C, 40°C-130°C, 40°C-125°C, 40°C-120°C, 70°C-130°C, 70°C-125°C, 70°C-120°C, 80°C-130°C, 80-125°C, 80°C-120°C, 60°C-100°C, 60°C-90°C, 70°C-100°C, 70°C-90°C, 75°C-100°C, 75°C-90°C, 75°C-85°C, or 1°C-130°C.

[0160] The pH of the aqueous medium in which the solid compositions herein may be contained may be, for example, about 4.0, 4.5, 5.0, 5.5, 6.0, 6.5, 7.0, 7.5, 8.0, 8.5, 9.0, 9.5, 10.0, 10.5, 4.0-10.0, 4.0-9.0, 4.0-8.0, 5.0-10.0, 5.0-9.0, 5.0-8.0, 6.0-10.0, 6.0-9.0, or 6.0-8.0.

[0161] The amount of time wherein the solid compositions herein can be in an aqueous medium can be, for example, about, or at least about 0.5, 1, 5, 10, 30, 60, 90, 120, 150, 180, 210, 240, 300, 360, 420, 480, 540, 600, 660, or 720 minutes, 0.5, 1, 2, 4, 6, 8, 10, 20, 30, 60, 90, 120, 150, 180, 210, 240, 270, 300, 330, or 360 days, or 1, 2, or 3 years.

[0162] The aqueous compositions herein can have, for example, about, at least about, or less than about 1, 5, 10, 100, 200, 300, 400, 500, 600, 700, 1000, 2000, 3000, 4000, 5000, 6000, 7000, 8000, 9000, 10000, 15000, 1-300, 10-300, 2 The viscosity of the aqueous composition of the present invention can be 5-300, 50-300, 1-250, 10-250, 25-250, 50-250, 1-200, 10-200, 25-200, 50-200, 1-150, 10-150, 25-150, 50-150, 1-100, 10-100, 25-100, or 50-100 centipoise (cps). For example, the viscosity can be measured as with the aqueous composition herein at any temperature between about 3°C ​​to about 80°C (e.g., 4°C-30°C, 15°C-30°C, 15°C-25°C). The viscosity is typically measured as at atmospheric pressure (about 760 Torr) or at a pressure of ±10% thereof. Viscosity can be measured using, for example, a viscometer or rheometer, and can optionally be measured, for example, at about 0.1, 0.5, 1.0, 5, 10, 50, 100, 500, 1000, 0.1-500, 0.1-100, 1.0-500, 1.0-1000, or 1.0-100 s -1 The shear rate (rotational shear rate) was measured at 1 / s.

[0163] In some aspects, the solid composition herein can have a positive surface charge or a negative surface charge; in some aspects, there is no (or very small, such as less than ± 0.02 or ± 0.015mV) surface charge (i.e., neutral charge). "±" herein refers to positive / plus or negative / minus. Typically, the cationic or anionic surface charge is due to the charge (or average charge) of one or more charged additives contained in the solid composition. For example, the surface charge can be measured with a solid composition in water (e.g., as a dispersion) and / or with a solid composition in particulate form (e.g., fibrids, powders) expressed as a zeta potential. In some aspects, the zeta potential of the solid composition can be about or more than about ± 5mV, ± 10mV, ± 15mV, ± 20mV, ± 25mV, ± 30mV, ± 35mV, ± 40mV, ± 45mV, or ± 50mV. For illustration purposes only, it should be understood that, for example, a zeta potential "exceeding" ±5 mV excludes a zeta potential ranging from -5 mV to +5 mV. In some aspects, the zeta potential is about +20 to +40 mV, +25 to +40 mV, +30 to +40 mV, +20 to +45 mV, +25 to +45 mV, +30 to +45 mV, +20 to +50 mV, +25 to +50 mV, or +30 to +50 mV. In some aspects, the foregoing zeta potential values ​​may be associated with an aqueous composition having a pH of about 6.5-7.5, 6-8, 5-9, or 4-9.

[0164] In some aspects herein, wherein the solid composition is included in a non-caustic aqueous medium (e.g., water), and the additive of the solid composition is aqueous soluble (water soluble) under non-caustic conditions. For example, about or at least about 80wt%, 85wt%, 90wt%, 95wt%, 96wt%, 97wt%, 98wt%, 99wt%, 100wt%, 80-100wt%, 80-99wt%, 80-97wt%, 90-100wt%, 90-99wt%, 90-97wt%, 95-100wt%, 95-99wt%, or 95-97wt% of the aqueous soluble additive can be included in the solid composition (remaining included in the solid composition and not dissolved in the aqueous medium). This aspect is also established despite the presence of water, but it may additionally dissolve soluble additives. Thus, in some aspects, the aqueous medium can contain about, or less than about 20 wt%, 15 wt%, 10 wt%, 5 wt%, 4 wt%, 3 wt%, 2 wt%, 1 wt%, 0 wt%, 0-20 wt%, 1-20 wt%, 3-20 wt%, 0-10 wt%, 1-10 wt%, 3-10 wt%, 0-5 wt%, 1-5 wt%, or 3-5 wt% of an aqueous soluble additive that is initially / initially completely contained in the solid composition (before the solid composition is placed in the aqueous medium).

[0165] Thus, some aspects of the present disclosure relate to a method of treating a solid composition herein (e.g., a hybrid solid composition, such as a fibrid, fiber, extrudate, composite, powder, or film / coating herein). Such a method may include: (a) providing a solid composition herein, and (b) contacting the solid composition with a non-caustic aqueous liquid (or subjecting the solid composition to non-caustic aqueous conditions / treatment / washing under non-caustic aqueous conditions), wherein the contacting does not remove any additives from the solid composition, or the contacting removes less than 20 wt % of the additives from the solid composition). The non-caustic aqueous liquid may be any liquid as disclosed herein (e.g., water), have any relevant characteristics (e.g., temperature, non-caustic pH), and / or be contacted for a suitable amount of time (e.g., as disclosed herein). The volume of the liquid used in the treatment method herein may be, for example, about or at least about 0.25, 0.5, 1.0, 2, 3, 4, 5, 6, 7, 9, or 10 times the volume of the solid composition. Contacting may optionally be performed two, three, four, or more times (eg, iteratively, such as in a wash), and / or may include some form of agitation (eg, mixing, slurrying). The treatment methods of the present disclosure may optionally further comprise separating (e.g., via filtration or decantation) all or a majority (e.g., at least about 50, 60, 70, 80, 90, 95, 96, 97, 98, 99, or 99.5 wt%) of the non-caustic aqueous liquid from the solid composition, wherein the non-caustic aqueous liquid (when it is present after separation) does not contain any additives (e.g., additives that are not dissolved in the liquid), or contains about or less than about 20, 15, 10, 5, 4, 3, 2, 1, 0, 0-20, 1-20, 3-20, 0-10, 1-10, 3-10, 0-5, 1-5, or 3-5 wt% of the additives that were in the solid composition prior to the contacting step. The separation step can be performed, for example, after each contacting step. The aforementioned concentration values ​​can characterize the liquid used in any contacting step (e.g., the first contacting step, and, if performed, the second or additional contacting step). One or more additives in some aspects of the treatment method can be water-soluble under non-caustic conditions (e.g., any such additive disclosed herein, such as a charged additive). The charged additive can be, for example, a charged polysaccharide or a charged polysaccharide derivative herein.

[0166] Solid compositions herein, when not included in an aqueous medium, typically can be considered as non-aqueous (for example, dry compositions). The example of such embodiments includes powder, granule, microcapsule, thin slice or any other form of particulate matter. Other examples include larger compositions, such as pellets, rods, cores, beads, tablets, sticks or other agglomerates. Non-aqueous compositions or dry compositions typically have about or no more than about 5wt%, 4wt%, 3wt%, 2wt%, 1.5wt%, 1.0wt%, 0.5wt%, 0.25wt%, 0.10wt%, 0.05wt% or 0.01wt% water included therein.

[0167] In some aspects, the solid composition can be a fiber (e.g., a filament). The product / composition comprising the fiber can be a nonwoven product, a woven product (textile), or any other fiber-containing product. The fabric herein can be a nonwoven or a woven.

[0168] Materials / articles / products containing one or more of the fabrics herein include, for example, clothing (e.g., exercise / fitness / sports clothing), curtains, shower curtains, drapes, upholstery, carpets, bedding, bath towels, towels, tablecloths, sleeping bags, tents, automobile interiors, laundry containers, etc.

[0169] The nonwoven product (eg, nonwoven fabric, nonwoven web) herein may be, for example, airlaid, drylaid, wetlaid, carded, electrospun, spun-lace, or spunbond (directly spun / direct spinning). In some aspects, the nonwoven product can be an abrasive or scouring sheet, an agricultural mulch, an agricultural seed strip, a garment lining, an automotive roof lining or interior trim, a bib, a cheese covering, a geotextile, a coffee filter, a cosmetic remover or applicator, a detergent pouch / sachet, a fabric softener sheet, an envelope, a facial film, a filter, a garment bag, a thermally or electrically conductive fabric, a home care wipe (e.g., for floor care, hard surface cleaning, pet care, etc.), a house covering, a hygiene product (e.g., a sanitary pad / tissue, a medical mattress), an insulation material, a label, a clothing aid, a medical care or personal injury care product (e.g., a bandage, a plaster bandage pad or plaster cover, a dressing, a bag, a sterile outer packaging, a sterile packaging, a surgical drape, a surgical gown, a swab), a mop, a napkin or tissue, paper, a personal wipe or baby wipe, a reusable bag, a roof covering, a tablecloth, a sign, a tea bag or coffee bag, an upholstery, a vacuum cleaning bag, or a wall covering. Examples of the nonwoven products and / or methods of producing nonwoven products herein may be as disclosed in U.S. Patent Application Publication Nos. 2020 / 0370216, 2018 / 0282918, 2017 / 0167063, 2018 / 0320291, 2018 / 0340270, 2016 / 0053406, or 2010 / 0291213, each of which is incorporated herein by reference.

[0170] The fiber-containing product herein can be a paper / packaging composition or a composition containing cellulose fibers. The example of such composition includes paper (e.g., writing paper, office paper, copy paper, kraft paper), cardboard, cardboard, corrugated board, tissue, napkin / paper towel, wipes or nonwoven fabric. The formula and / or components (except those herein) of the paper / packaging composition or the composition containing cellulose fibers herein and the form of these compositions can be as described in, for example, U.S. Patent Application Publication Nos. 2018 / 0119357, 2019 / 0330802, 2020 / 0062929, 2020 / 0308371 or 2020 / 0370216, and these applications are each incorporated herein by reference.

[0171] In some aspects, the nonwoven product (fabric) or woven product (fabric) has a weight of about, or at most about 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 45, 50, 55, 60, 65, 70, 80, 90, 100, 25-50, 25-45, 25-40, 25-35, 25-33, 25-32, 28-50, 28-45, 28-40, 28-35, 28-33, 28-32, 28-31, 29-32, 29-31, 50-70, 50-65, 55-70, or 55-65 gsm (grams per square meter [of fabric]).

[0172] In some aspects, the solid composition can be an extruded product.Examples of extruded products include fibers (filaments), tubular products (e.g., tubes, pipes, straws such as drinking straws), bags, sheets, films, washers, and rods.

[0173] In some aspects, the compositions herein (e.g., films, coatings, fibers [e.g., filaments], fibrids, extrudates, composites) have a tensile strength (ultimate tensile strength) of about or at least about 35, 40, 45, 50, 55, 60, 65, 35-65, 40-65, 45-65, 35-60, 40-60, 45-60, 35-55, 40-55, or 45-55 MPa (megapascals). The tensile strength can be measured as described in the following examples (e.g., wherein each condition / parameter is within 5%, 10%, or 15% of the relevant condition / parameter disclosed in the examples) or, for example, as disclosed in DIN EN ISO 527-3 (which is incorporated herein by reference). In some aspects, the tensile strength of the compositions herein comprising one or more additives is about or at least about 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 100%, 110%, 120%, 130%, 140%, or 150% higher than the tensile strength of the same composition except for the absence of the one or more additives.

[0174] In some aspects, the compositions herein (e.g., films, coatings, fibers [e.g., filaments], fibrids, extrudates, composites) have an elongation at break (percent elongation) of about or at least about 40%, 45%, 50%, 55%, 60%, 65%, 40-65%, 45-65%, 50-65%, 40-60%, 45-60%, or 50-60%. The percent elongation can be measured as described in the following examples (e.g., wherein each condition / parameter is within 5%, 10%, or 15% of the relevant condition / parameter disclosed in the examples) or, for example, as disclosed in DIN EN ISO 527-3 (which is incorporated herein by reference). In some aspects, the elongation percentage of the compositions herein comprising one or more additives is about or at least about 10%, 20%, 30%, 40%, 50%, 60%, 70%, or 80% higher than the elongation percentage of the same composition except for the absence of the one or more additives.

[0175] The films or coatings / layers of the compositions herein may have, for example, about, at least about, or less than about 1, 2.5, 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55, 60, 65, 70, 85, 90, 95, 100, 105, 110, 120, 130, 140, 150, 160, 170, 180, 190, 200, 10-30 In some aspects, the thickness is uniform and can be characterized by having a continuous area that (i) is at least 20%, 30%, 40%, or 50% of the total coating area and (ii) has a thickness standard deviation of less than about 0.5, 1, 1.5, or 2 microns.

[0176] In some aspects, the substrate is coated with one layer (single layer) of the coating composition herein. However, in some aspects, there may be multiple (e.g., two, three or more) coatings of the coating composition, and such additional coatings may be the same or different from the first coating. The coating herein may be, for example, one or more of the coatings contained in the laminate.

[0177] Film / coating herein can show various degrees of transparency according to expectation.For example, film / coating can be highly transparent (for example, high light transmittance and / or low haze).Optical transparency as used herein can for example refer to allow at least about 10%-99% light transmittance or at least about 50%, 60%, 70%, 80%, 90%, 95%, 96%, 97%, 98% or 99% light transmittance, and / or be less than the film / coating of 30%, 25%, 20%, 15%, 10%, 5%, 2.5%, 2% or 1% haze.High optical transparency can alternatively refer to the film / coating with at least about 90% light transmittance and / or be less than 10% haze. The light transmittance of the films / coatings herein can be measured, for example, following test ASTM D1746 (2009, Standard Test Method for Transparency of Plastic Sheeting, ASTM International, West Conshohocken, PA) (incorporated herein by reference). The haze of the films / coatings herein can be measured, for example, following test ASTM D1003-13 (2013, Standard Test Method for Haze and Luminous Transmittance of Transparent Plastics, ASTM International, West Conshohocken, PA) (incorporated herein by reference).

[0178] The film / coating herein may optionally further comprise a plasticizer, such as glycerol, propylene glycol, ethylene glycol, and / or polyethylene glycol. In some aspects, other film / coating components (except at least insoluble α-glucan and additives) may be as disclosed in U.S. Patent Application Publication Nos. 2011 / 0151224, 2015 / 0191550, or 20170208823, or U.S. Patent Nos. 9688035 or 3345200, all of which are incorporated herein by reference.

[0179] Film or other sheet products of the present disclosure can be, for example, in the form of film. In some respects, film can be used for separation or purification process, such as dialysis, biocomponent separation / purification or reverse osmosis (e.g., dialysis membrane, protein separation membrane, reverse osmosis membrane). As any solid composition / product of the present disclosure, in some alternative aspects, film does not include additives herein, wherein this additive will be present in the stock solution for producing film.

[0180] The films, sheets, or sheet-like products of the present disclosure can be used for application to (e.g., laying on, pressing onto) skin (e.g., human skin). Examples of skin suitable for this purpose are facial skin (e.g., entire face, nose, lips, eyelids, eyebrows, cheeks, chin, forehead) (a facial film is an example of such a product), ear skin, and body skin (e.g., arms, legs, trunk, hands, feet, stratum corneum, neck, scalp [typically if shaved]). For example, such a product can have any of the features of the films / coatings herein (e.g., thickness, insoluble α-glucan content, water content, transparency). As with any solid composition / product of the present disclosure, in some alternative aspects, the film product for skin application does not contain the additives herein, where such additives would be present in the stock solution used to produce the film product. Whether or not the film product for skin application contains additives carried by the stock solution, the film product can be treated / modified (e.g., impregnated) after its production to contain one or more additives / agents, typically wherein such one or more additives / agents provide therapeutic benefits, cosmetic benefits, or any other benefits to the skin targeted by the film product. Examples of such one or more additives / agents (skin treatment agents) include enzymes, vitamins (e.g., vitamin C), minerals, drugs, keratolytic agents (e.g., salicylic acid, azelaic acid), anti-acne agents (e.g., salicylic acid, benzoyl peroxide), skin lightening agents, anti-wrinkle / fold agents, antioxidants, moisturizers, oil-reducing (anti-sebum) agents, hyaluronic acid, glycolic acid, ceramides, charcoal, clay, activated carbon, and curcumin (and / or any suitable additive disclosed herein). One or more of these or other skin treatment agents may optionally be appropriate stock solution additives (as appropriate) (in addition to or in place of additives added to the film product after film formation). The thin film products for skin application herein may be adapted for manufacture and / or use accordingly, for example, as disclosed in US Pat. Nos. 8,425,477, 5,538,732, or 10,448,727, each of which is incorporated herein by reference.

[0181] In some aspects, one side of the film / coating is hydrophilic and the other side of the film / coating is hydrophobic (e.g., a characteristic of a film / coating having at least one additive herein that is an oil). Such a film / coating may optionally be characterized as having a "surface polarity" in terms of water attraction / repulsion. The hydrophobicity or hydrophilicity of a film or coating surface may be determined, for example, by measuring the contact angle of water in direct contact with the surface. For example, a water drop in contact with a hydrophobic surface may exhibit a contact angle of about or at least about 85°, 90°, 95°, 100°, 105°, 85°-105°, 90°-105°, 95°-105°, 85°-100°, 90°-100°, 95°-100°, 85°-95°, or 90°-95°, and / or a water drop in contact with a hydrophilic surface may exhibit a contact angle of about or less than about 80°, 75°, 70°, 65°, 60°, 55°, 50°, 45°, 45°-80°, 45°-75°, or 45°-70°. The film / coating may have, for example, one side that is more hydrophilic (or hydrophobic) than the other side (e.g., >10%, 20%, 30%, or 40% greater).

[0182] Some aspects describe a coating on a substrate herein, and the side of the coating opposite to the side of the coating contacting the substrate is hydrophobic (i.e., the outside or the side facing the outside of the coating is hydrophobic), while the side in contact with the substrate (i.e., the side facing the inside of the coating) is hydrophilic. In such aspects, the coating typically adheres better to (e.g., at least 10%, 20%, 30%, 40%, or 50% better) substrates with hydrophilic surfaces compared to neutral surfaces or hydrophobic surfaces, and / or compared to coatings herein without surface polarity. In such aspects, the coating typically repels water better (e.g., at least 10%, 20%, 30%, 40%, or 50% better) than coatings herein without surface polarity.

[0183] The substrate that can be coated with the composition herein can include or be, for example, a cellulose substrate, glass, leather, metal, a non-cellulose-based polymer or fiber material, masonry, drywall, plaster, wood, a building surface, or a food (e.g., fruit or vegetable). Examples of non-cellulose-based polymers herein include rubber (e.g., natural rubber) or other diene-based elastomers, polyamides, polyolefins, polylactic acid, polyethylene terephthalate (PET), poly(trimethylene terephthalate) (PTT), aramids, polyethylene sulfide (PES), polyphenylene sulfide (PPS), polyimide (PI), polyethyleneimine (PEI), polyethylene naphthalate (PEN), polysulfone (PS), polyetheretherketone (PEEK), polyethylene, polypropylene, poly(cycloolefin), poly(cyclohexylene dimethylene terephthalate) and poly(trimethylene furandicarboxylate) (PTF). In some respects, the cellulose substrate comprises about or at least about 80 % by weight, 82.5 % by weight, 85 % by weight, 87.5 % by weight, 90 % by weight, 91 % by weight, 92 % by weight, 93 % by weight, 94 % by weight, 95 % by weight, 96 % by weight, 97 % by weight, 98 % by weight, 99 % by weight, 99.5 % by weight or 100 % by weight of cellulose (typically in the form of cellulose fibers). Other components of the cellulose substrate may alternatively include hemicellulose and / or lignin. The cellulose substrate is typically porous. In some respects, the substrate may be a weaving or nonwoven material (e.g., weaving or nonwoven fabric).

[0184] In some aspects, the cellulose substrate can be a paper product, a woven product or a nonwoven product. The example of a paper product includes paper, cardboard, cardboard, corrugated board, boxboard and molded or compressed paper fibers. Another example of a paper product is a paper straw (drinking straw). The aforementioned is also an example of a composition or product comprising a cellulose substrate herein. In some aspects, a composition or product comprising a cellulose substrate herein can be a package or container, and typically includes one or more of the aforementioned paper products. The example of a package and / or container herein includes a box (for example, a cardboard box, a cardboard box, a corrugated box, a hard box), a particleboard, a paper box (for example, a beverage box, a folding carton), a bag, a cup, a plate, a wrapping paper / packaging material, a pipe / tubing, a cone egg roll, a French fry holder or a similar holder, a tray, tissue paper, parchment paper and kraft paper. Although one side of a paper product can be covered with foil (for example, foil sealed) such as aluminum foil or plastic, the paper product herein typically does not include such a covering. The package or container may be closed (eg, hermetically closed) or open (eg, unsealed).

[0185] For example, a coating composition as applied to a substrate herein can cover the entire area of ​​one or both sides of the substrate or at least about 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, or 99.5% of the area. With respect to compositions or products having an interior surface and an exterior surface (e.g., boxes, cartons, French fry trays), the coating can be on the interior surface, the exterior surface, or both surfaces.

[0186] In some aspects, the compositions herein (such as packaging or containers) hold products, optionally wherein the coating (typically on the inner / inner surface of the packaging / container) contacts the product. Such products can be, for example, ingestible products (e.g., food products), pharmaceutical products, personal care products, household care products, or industrial products. Examples of these types of products are described in U.S. Patent Application Publication Nos. 2018 / 0022834, 2018 / 0237816, 2018 / 0230241, 20180079832, 2016 / 0311935, 2016 / 0304629, 2015 / 0232785, 2015 / 0368594, 2015 / 0368595, 2016 / 0122445, 2019 / 0202942, or 2019 / 0309096, or International Patent Application Publication No. WO2016 / 133734, all of which are incorporated herein by reference. In some aspects, a package or container holds at least one component / ingredient of an ingestible product (e.g., a food product), a pharmaceutical product, a personal care product, a household care product, or an industrial product, and a coating of the package or container is optionally in contact therewith, as disclosed in any of the aforementioned publications and / or as disclosed herein.

[0187] In some aspects, the product contained in the package / container includes oil, grease and / or water on its surface, and the product contacts the inner surface of the package / container (optionally, if the layer of the coating composition is just located on the inner surface of the package / container, the product contacts the layer). Typically, at least a portion (e.g., at least about 80, 85, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 99.5 wt%) of the oil, grease and / or water of the product or all of it is contained inside the package or container. In other words, most or all of the oil, grease and / or water cannot pass through the package or container to reach the outer / exterior surface of the package or container.

[0188] The compositions herein can be at a temperature of, for example, about 1°C-50°C, 1°C-45°C, 1°C-40°C, 1°C-35°C, 1°C-30°C, 1°C-25°C, 1°C-20°C, 5°C-30°C, 10°C-30°C, 15°C-30°C, 20°C-30°C, 5°C-25°C, 10°C-25°C, 15°C-25°C, or 20°C-25°C (or any other temperature disclosed herein) and / or in an environment / system having the above temperatures. The composition herein can be in an environment with a relative humidity level of, for example, about or at least about 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 100%, 20%-100%, 30%-100%, 40%-100%, 50%-100%, 60%-100%, 70%-100%, 80%-100%, 20%-90%, 30%-90%, 40%-90%, 50%-90%, 60%-90%, 70%-90% or 80%-90%. An illustrative example of a composition that can be in any of the aforementioned temperature and / or relative humidity conditions is a wrapper or container for containing a product herein.

[0189] Typically, the products herein (e.g., pharmaceutical products, personal care products, household care products, industrial products, or ingestible products such as food products), if stored in closed or sealed packages / containers herein (e.g., 1, 2, 3, 6, 9, 12, 18, 24, 30, or 36 months), can be protected from exposure to water, water vapor, and / or oxygen from outside the packages / containers. For example, such storage prevents the product from spoiling and / or becoming stale, or any other form of decay or loss of freshness or functionality.

[0190] Compositions as disclosed herein—e.g., hybrid solid compositions such as fibers [e.g., filaments], fibrids, extrudates, composites, powders, or films / coatings herein—can be in the form of or contained within, for example, household care products, personal care products, industrial products, ingestible products (e.g., food products), medical products, or pharmaceutical products, such as described in any of the following: U.S. Patent Application Publication Nos. 2018 / 0022834, 2018 / 0237816, 2018 / 02 30241, 20180079832, 2016 / 0311935, 2016 / 0304629, 2015 / 0232785, 2015 / 0368594, 2015 / 0368595, 2016 / 0122445, 2019 / 0202942, 2019 / 0309096 or 2021 / 0130504, or International Patent Application Publication No. WO2016 / 133734, all of which are incorporated herein by reference. In some aspects, the composition may include at least one component / ingredient of a household care product, personal care product, industrial product, pharmaceutical product, medical product, or ingestible product (e.g., food product) as disclosed in any of the aforementioned disclosures and / or as disclosed in the present invention.

[0191] It is believed that in some aspects, the compositions can be used to provide one or more of the following physical properties to personal care products, pharmaceutical products, household products, industrial products, or ingestible products (e.g., food products): for example, thickening, freeze / thaw stability, lubricity, water retention and release, texture, consistency, shape retention, emulsification, binding, suspension, dispersion, gelling, reduced mineral hardness.

[0192] In some alternative aspects, the solid composition / product can be any of those disclosed herein, but does not further comprise an additive, wherein such an additive would be present in the stock solution used to produce the solid composition / product (i.e., such solid composition / product is not "mixed" as disclosed elsewhere herein).

[0193] Non-limiting examples of the compositions and methods disclosed herein include:

[0194] 1. A solution (e.g., a caustic solution / stock solution) comprising at least (a) a caustic solvent, (b) α-glucan and / or a derivative thereof (or α-glucan cross-linked before entering the caustic solvent) (typically wherein the α-glucan or its derivative [or pre-cross-linked α-glucan] is aqueous-insoluble under non-caustic conditions), and (c) an additive, wherein the additive is (i) a cross-linking agent, and / or (ii) an additive that optionally does not chemically react with the α-glucan or its derivative (optionally no additive is used if α-glucan cross-linked before entering the caustic solvent is used), wherein at least about 50% of the glycosidic bonds of the α-glucan are α-1,3 glycosidic bonds, and the α-glucan has a weight average degree of polymerization of at least 15, wherein the α-glucan or its derivative is soluble in the caustic solvent, and the additive is soluble or insoluble in the caustic solvent.

[0195] 2. The solution of embodiment 1, wherein at least about 90% of the glycosidic bonds of the α-glucan are α-1,3 glycosidic bonds.

[0196] 3. The solution of embodiment 1 or 2, wherein the solution comprises the α-glucan (ie, non-derivatized α-glucan).

[0197] 4. The solution of embodiment 1, 2, or 3, wherein the solution comprises about 5 wt % to about 20 wt % (e.g., 7.5 wt % to 15 wt %) of the α-glucan and / or its derivative.

[0198] 5. The solution of embodiment 1, 2, 3, or 4, wherein the additive is the cross-linking agent.

[0199] 6. The solution of embodiment 1, 2, 3, or 4, wherein the additive is an additive that does not react with the α-glucan or its derivative.

[0200] 7. The solution of embodiments 1, 2, 3, 4, 5, or 6, wherein the additive is aqueous soluble (e.g., water soluble) under non-caustic conditions.

[0201] 8. The solution of any one of embodiments 1, 2, 3, 4, 5, 6, or 7, wherein the additive is a polysaccharide derivative.

[0202] 9. The solution of Embodiment 1, 2, 3, 4, 5, 6, 7, or 8, wherein the caustic solvent is an aqueous alkali metal hydroxide.

[0203] 10. The solution of Embodiment 1, 2, 3, 4, 5, 6, 7, 8, or 9, wherein the solution is in the form of stock solution filaments.

[0204] 11. A method for producing a solution as described in any one of embodiments 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10, the method comprising: mixing at least the α-glucan and / or its derivative and the additive with a caustic solvent, wherein the α-glucan and / or its derivative is dissolved in the caustic solvent.

[0205] 12. A method for producing a solid composition, the method comprising: (a) providing a solution as described in any one of embodiments 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10 or a solution produced by the method as described in embodiment 11, (b) putting the solution into a desired form / shape, and (c) removing the caustic solvent from the solution of step (b) to produce a solid composition comprising the α-glucan or its derivative and the additive.

[0206] 13. A method as described in Example 12, wherein the step of removing the solvent comprises: (i) chemically or ionically modifying the caustic solvent (chemically or ionically modifying the solution) so that the α-glucan or its derivative and the additive - if they are dissolved in the solvent - are no longer dissolved in the caustic solvent, or (ii) blowing air into the solution so that the α-glucan or its derivative and the additive - if they are dissolved in the solvent - are no longer dissolved in the caustic solvent.

[0207] 14. The method of embodiment 12 or 13, wherein the solid composition of step (c) is a fiber (eg, filament), an extrudate, a fibrid, a composite, a powder, or a film / coating.

[0208] 15. A method as described in Example 12 or 13, wherein step (b) includes using a device (e.g., a spinneret) having one or more orifices (e.g., holes, nozzles, or perforations) through which the solution is transmitted / discharged / jetted / pushed, optionally wherein fibers (e.g., filaments) are produced in step (c).

[0209] 16. A composition comprising a solid composition produced by the method of embodiment 12, 13, 14, or 15, optionally wherein the solid composition is a fiber (e.g., filament), an extrudate, a fibrid, a composite, a powder, or a film / coating.

[0210] 17. A composition comprising a solid composition comprising at least water-insoluble α-glucan and / or its water-insoluble derivatives, wherein (i) the α-glucan and / or its derivatives are cross-linked, and / or (ii) the composition further comprises an additive that is not chemically linked to the α-glucan or its derivatives, wherein at least about 50% of the glycosidic bonds of the α-glucan are α-1,3 glycosidic bonds, and the weight average degree of polymerization of the α-glucan is at least 15.

[0211] 18. The composition of embodiment 17, wherein the solid composition is a fiber (eg, filament), fibrid, extrudate, composite, powder, or film / coating.

[0212] 19. The composition of embodiment 17, wherein the solid composition is a fiber (eg, a filament) and the fiber is contained in a nonwoven product or other fiber-containing product herein.

[0213] Non-limiting examples of the compositions and methods disclosed herein include:

[0214] 1b. A composition comprising fibrids (hybrid fibrids) (or other hybrid solid compositions, such as fibers [e.g., filaments] herein), extrudates, composites, powders, or films / coatings), wherein the fibrids comprise water-insoluble α-glucan and an additive, wherein (i) at least about 50% of the glycosidic bonds of the α-glucan are α-1,3 glycosidic bonds and the weight average degree of polymerization of the α-glucan is at least 15, and (ii) the additive is not chemically bonded to the α-glucan.

[0215] 2b. The composition of embodiment 1b, wherein at least about 90% of the glycosidic bonds of the α-glucan are α-1,3 glycosidic bonds.

[0216] 3b. The composition of embodiment 1b or 2b, wherein the α-glucan has a weight average degree of polymerization of at least 400.

[0217] 4b. The composition of embodiment 1b, 2b, or 3b, wherein the additive is aqueous soluble (eg, water soluble) under non-harsh conditions.

[0218] 5b. The composition of embodiment 1b, 2b, or 3b, wherein the additive is aqueous-insoluble (eg, water-insoluble) under non-harsh conditions.

[0219] 6b. The composition of Embodiment 1b, 2b, 3b, 4b, or 5b, wherein the fibrids (or other solid composition) comprise at least about 0.5 wt % of the additive and up to about 99.5 wt % of the water-insoluble α-glucan.

[0220] 7b. The composition of embodiment 1b, 2b, 3b, 4b, 5b, or 6b, wherein the additive comprises a charged additive.

[0221] 8b. The composition of embodiment 7b, wherein the charged additive is a cationic additive (or anionic additive).

[0222] 9b. The composition of embodiment 8b, wherein the cationic additive is a cationic polysaccharide derivative (eg, ether) (or a cationic underivatized polysaccharide).

[0223] 10b. The composition of embodiment 9b, wherein the polysaccharide of the cationic polysaccharide derivative is α-glucan, wherein at least about 50% of the glycosidic bonds of the α-glucan are α-1,3 glycosidic bonds, and the α-glucan has a weight average degree of polymerization of at least 15.

[0224] 11b. The composition of embodiment 9b or 10b, wherein the cationic polysaccharide derivative (or the cationic underivatized polysaccharide) is water-soluble (or water-insoluble) under non-harsh conditions.

[0225] 12b. The composition of embodiment 9b, 10b, or lib, wherein the cationic polysaccharide derivative comprises ether-linked cationic organic groups.

[0226] 13b. The composition of embodiment 12b, wherein the ether-linked cationic organic group is a substituted ammonium group.

[0227] 14b. A composition as described in Examples 1b, 2b, 3b, 4b, 5b, 6b, 7b, 8b, 9b, 10b, 11b, 12b, or 13b, wherein the fibrids (or the other solid composition) are contained in an aqueous medium (e.g., water or other non-caustic aqueous medium).

[0228] 15b. The composition of embodiment 14b, wherein the additive is aqueous soluble (eg, water soluble) under non-harsh conditions.

[0229] 16b. The composition of embodiment 14b or 15b, wherein at least about 80 wt % of the additive is contained in the fibrids (or the other solid composition) (ie, less than 20 wt % of the additive is dissolved in the aqueous medium).

[0230] 17b. A method for treating fibrids (hybrid fibrids) (or other solid compositions, such as fibers [e.g., filaments], extrudates, composites, powders, or films / coatings herein), the method comprising: (a) providing fibrids (or other solid compositions, such as fibers [e.g., filaments], extrudates, composites, powders, or films / coatings herein) as described in Examples 1b, 2b, 3b, 4b, 5b, 6b, 7b, 8b, 9b, 10b, 11b, 12b, or 13b, and (b) contacting the fibrids (or the other solid compositions) with a non-harsh aqueous liquid (or subjecting them to non-harsh aqueous conditions / treating them under non-harsh aqueous conditions), wherein the contacting does not remove any of the additives from the fibrids (or the other solid compositions), or the contacting removes less than 20 wt% of the additives from the fibrids (or the other solid compositions).

[0231] 18b. A method as described in Example 17b, further comprising separating the non-caustic aqueous liquid from the fibrids (or the other solid composition), wherein the non-caustic aqueous liquid does not contain any of the additives (e.g., additives that are insoluble in the liquid), or the non-caustic aqueous liquid contains less than 20 wt % of the additives present in the fibrids (or the other solid composition) prior to the contacting step (b).

[0232] 19b. The method of embodiment 17b or 18b, wherein the additive is aqueous soluble (eg, water soluble) under non-harsh conditions.

[0233] 20b. The composition of embodiment 17b, 18b, or 19b, wherein the additive comprises a charged additive.

[0234] Non-limiting examples of the compositions and methods disclosed herein include:

[0235] 1c. A film / coating composition (or other hybrid solid composition, such as fibers [e.g., filaments], fibrids, extrudates, composites, or powders herein) comprising a water-insoluble α-glucan and a hydrophobic additive, wherein (i) at least about 50% of the glycosidic bonds of the α-glucan are α-1,3 glycosidic bonds and the α-glucan has a weight average degree of polymerization of at least 15, and (ii) the hydrophobic additive is not chemically bonded to the α-glucan.

[0236] 2c. The film / coating composition (or other hybrid solid composition) of embodiment 1c, wherein at least about 90% of the glycosidic bonds of the α-glucan are α-1,3 glycosidic bonds.

[0237] 3c. The film / coating composition (or other hybrid solid composition) of embodiment 1c or 2c, wherein the α-glucan has a weight average degree of polymerization of at least 400.

[0238] 4c. The film / coating composition (or other hybrid solid composition) of Embodiment 1c, 2c, or 3c, wherein the hydrophobic additive is aqueous-insoluble (eg, water-insoluble) under both harsh and non-harsh conditions.

[0239] 5c. The film / coating composition (or other hybrid solid composition) of Embodiment 1c, 2c, 3c, or 4c, wherein the hydrophobic additive can form an emulsion under harsh conditions and non-harsh aqueous conditions.

[0240] 6c. A film / coating composition (or other hybrid solid composition) as described in Examples 1c, 2c, 3c, 4c, or 5c, wherein the hydrophobic additive comprises oil (e.g., rapeseed oil, canola oil) (or other hydrophobic additive that is a liquid that can be dispersed in harsh aqueous conditions).

[0241] 7c. The film / coating composition (or other hybrid solid composition) of Embodiment 1c, 2c, 3c, 4c, or 5c, wherein the hydrophobic additive comprises a wax.

[0242] 8c. A film / coating composition (or other mixed solid composition) as described in Examples 1c, 2c, 3c, 4c, 5c, 6c, or 7c, comprising about 0.05 wt % to about 50 wt % of the hydrophobic additive, wherein the wt % is based on the weight of the α-glucan in the film / coating composition.

[0243] 9c. A film / coating composition (or other hybrid solid composition) as described in Examples 1c, 2c, 3c, 4c, 5c, 6c, 7c, or 8c, wherein one side of the film / coating is hydrophilic and the other side of the film / coating is hydrophobic (i.e., the film / coating exhibits surface polarity in terms of water attraction / repulsion).

[0244] 10c. A film / coating composition (or other hybrid solid composition) as described in Examples 1c, 2c, 3c, 4c, 5c, 6c, 7c, 8c, or 9c, wherein the film / coating composition is a coating on a substrate and the coating side opposite to the side of the coating in contact with (adjacent to) the substrate (external coating side) is hydrophobic (and the side in contact with the substrate is hydrophilic).

[0245] 11c. A film / coating composition (or other mixed solid composition) as described in Examples 1c, 2c, 3c, 4c, 5c, 6c, 7c, 8c, 9c, or 10c, wherein the film / coating composition has: (i) a tensile strength (ultimate tensile strength) of at least about 35 MPa and / or (ii) an elongation percentage (elongation at break percentage) of at least about 40%.

[0246] 12c. A method for producing a film / coating composition (or other hybrid solid composition) as described in Examples 1c, 2c, 3c, 4c, 5c, 6c, 7c, 8c, 9c, 10c, or 11c, the method comprising: (a) providing a preparation comprising at least (i) a caustic solvent, (ii) the water-insoluble α-glucan, and (iii) the hydrophobic additive, wherein the α-glucan is dissolved in the caustic solvent; (b) contacting the preparation with a substrate (so that the preparation is in the form / shape of the film or coating) (or so that the preparation is in a desired form / shape, such as a fiber [e.g., filament], fibrid, or extrudate); and (c) removing the caustic solvent from the preparation of step (b) to produce a film / coating composition (or other hybrid solid composition, such as a fiber [e.g., filament], fibrid, or extrudate) comprising the α-glucan and the additive.

[0247] 13c. The method of embodiment 12c, wherein the formulation is a dispersion, and wherein the hydrophobic additive is dispersed in the caustic solvent.

[0248] 14c. The method of embodiment 12c or 13c, wherein the dispersion is an emulsion (or the formulation is an emulsion), wherein the hydrophobic additive is dispersed as an emulsion in the caustic solvent (i.e., the hydrophobic additive is a liquid that is immiscible with the caustic solvent).

[0249] 15c. A method as described in Example 12c, 13c, or 14c, wherein the step of removing the caustic solvent comprises: (i) chemically or ionically modifying the caustic solvent (chemically or ionically modifying the preparation) so that the α-glucan is no longer soluble in the caustic solvent, or (ii) air blowing the preparation so that the α-glucan is no longer soluble in the caustic solvent.

[0250] 16c. The method of embodiment 12c, 13c, 14c, or 15c, wherein the substrate comprises glass.

[0251] 17c. The method of embodiment 12c, 13c, 14c, or 15c, wherein the substrate is a cellulosic substrate (eg, paper, cardboard, paperboard, corrugated board, or boxboard).

[0252] 18c. A method as described in Examples 12c, 13c, 14c, 15c, 16c, or 17c, further comprising the step of heating the film / coating composition (or other mixed solid composition, such as fibers [e.g., filaments], extrudates, fibrids, powders, or composites) to a temperature of at least about 45°C (or a temperature that melts the hydrophobic additive, optionally if the hydrophobic additive is solid at 20°C-25°C).

[0253] 19c. The method of embodiments 12c, 13c, 14c, 15c, 16c, 17c, or 18c, wherein the hydrophobic additive has a melting temperature of at least about 45°C.

[0254] 20c. A film / coating (or other mixed solid composition, such as a fiber [e.g., filament], extrudate, fibrid, or composite) produced by the method described in Examples 12c, 13c, 14c, 15c, 16c, 17c, 18c, or 19c.

[0255] Examples

[0256] The present disclosure is further illustrated in the following examples. It should be understood that although these examples indicate certain aspects of the present invention, they are given by way of illustration only. From the above discussion and these examples, those skilled in the art can determine the essential characteristics of the disclosed embodiments, and various changes and modifications can be made to adapt the disclosed embodiments to a variety of uses and conditions without departing from the spirit and scope of the disclosed embodiments.

[0257] Materials / Methods

[0258] Representative method for preparing a solution (stock solution) of insoluble α-glucan

[0259] Unless otherwise disclosed, an α-glucan stock solution containing about 7.5-15 wt% α-1,3-glucan (DPw about 800, about 100% α-1,3 bonds, aqueous insoluble under non-caustic conditions) and about 4.2-4.5 wt% NaOH in water is prepared. Typically, the stock solution is prepared by charging the reactor with water and then adding the α-1,3-glucan dry powder under stirring. After the glucan powder becomes visibly evenly dispersed, the NaOH solution is added, after which the reactor contents are further stirred for about 30 minutes. The final α-1,3-glucan stock solution is clear and free of any color. One or more additives may be added before, during, or after the addition of the NaOH.

[0260] Example 1

[0261] Cross-linking of α-glucan in stock solution

[0262] In this example, various levels of ethylene glycol diglycidyl ether (EGDGE) crosslinker were added to a stock solution of α-1,3-glucan and its rheological properties were monitored.

[0263] A stock solution of 10 wt% water-insoluble α-1,3-glucan, 4.5 wt% NaOH, and 85.5 wt% water was prepared and divided into aliquots. Immediately after the stock solution was prepared, 0 wt%, 0.1 wt%, or 1 wt% EGDGE (relative to the weight of α-1,3-glucan in the stock solution) (PolySource, Independence, Mo.) was added to aliquots of the stock solution and stirred for 30 minutes using an overhead mixer with a propeller impeller (50 rpm). The rheological properties of each aliquot were then measured using an oscillating shear rheometer with cone-plate geometry (Malvern, Kinexus). The elastic modulus (G') and viscous modulus (G") were measured using an oscillation frequency of 1 Hz and by varying the strain from 0.1% to 100%. These measurements were performed immediately (day 0) or one day later. Table 1 below provides the G' and G" values ​​measured at a strain of 1%.

[0264] Table 1

[0265]

[0266]

[0267] It was observed (Table 1) that in the case where no (0wt%) EGDGE was added to the α-1,3-glucan stock solution, the corresponding differences in G' and G" were negligible from day 0 to day 1. However, in the case where 0.1wt% and 1wt% EGDGE were added, there was a significant increase in the corresponding G' and G" values ​​from day 0 to day 1, indicating that it took some time between 0-1 days for EGDGE cross-linking to occur completely. For the addition of 1wt% EGDGE, a corresponding increase in G' and G" was observed even on day 0 compared to the 0wt% and 0.1wt% EGDGE samples, indicating that cross-linking can occur rapidly at relatively higher EGDGE concentrations.

[0268] Example 2

[0269] Production of continuous stock filaments from cross-linked α-glucan stock solution

[0270] A stock solution with 7.5 wt% water-insoluble α-1,3-glucan and 4.5 wt% NaOH and 1 wt% EGDGE (relative to the weight of α-1,3-glucan in the stock solution) was prepared. After one day, this stock solution and the corresponding stock solution without EGDGE crosslinking agent were used separately in a fiber air blowing device equipped with a meltblowing die (Exxon type meltblowing die, fifty-eight 500 micron holes).

[0271] Air drawing of cross-linked (EGDGE treated) α-1,3-glucan stock solutions is possible with air flow pressures up to about 100 mbar without breakage of the stock filaments (producing continuous stock filaments); see Figure 1A In contrast, when attempting to air draw an α-1,3-dope solution containing no crosslinking agent, the process was not possible because every attempt thereto resulted in deformation and / or breakage of the air drawn dope (no uniform dope filaments could be produced); see Figure 1B These results were not foreseeable because the inclusion of a crosslinker might be expected to render the rheological conditions unsuitable for drawing continuous dope filaments.

[0272] Example 3

[0273] Fibers produced using cross-linked α-glucan stock solution

[0274] The fiber was produced using a stock solution with 7.5wt% water-insoluble α-1,3-glucan and 4.5wt% NaOH and 0.1wt%, 0.5wt%, or 1.0wt% EGDGE (relative to the weight of α-1,3-glucan in the stock solution). Each stock solution was made and kept for one day before entering fiber production. For fiber production, a fiber spinning nozzle with one hundred and twenty holes of 60 micrometer diameter was used. An extrusion speed of 13.3m / min and a spinning speed of 25m / min were used. When producing stock filaments, an increase in nozzle pressure proportional to the EGDGE content of each stock solution was observed (see Table 2 below). For coagulation of stock filaments into fibers, a solution containing 80g / L H2SO4, 220g / L Na2SO4 and 30g / LZnSO4 at 42°C was used. After coagulation, the fiber was washed with water and dried at 70°C.

[0275] Each of these fibers was tested for tenacity, elastic modulus (E-modulus) and elongation. Yarns (bundles of 120 fibers) of each prepared fiber were used for these tests. Table 2 below shows the results of these analyses.

[0276] Table 2

[0277]

[0278] Example 4

[0279] Films produced using cross-linked α-glucan stock solution

[0280] α-1,3-Glucan films were produced using a stock solution containing 1,4-butanediol diglycidyl ether (BDGE) or polyethylene glycol 2000 diglycidyl ether (PEG2000DGE) as a cross-linking agent.

[0281] A stock solution of α-1,3-glucan containing 15 wt% water-insoluble α-1,3-glucan, 4.9 wt% NaOH, and 80.1 wt% water was prepared, followed by the addition of 0 wt%, 0.01 wt%, or 0.05 wt% BDGE or 0.01 wt% PEG2000DGE (relative to the weight of α-1,3-glucan in the stock solution). A film was then cast onto a glass surface using a 100 micron doctor blade. The cast film was coagulated using a 5% H2SO4 / 2.5% Na2SO4 aqueous bath and washed with DI water until neutral. The film was then treated in a 5% glycerol aqueous bath and dried.

[0282] Each film produced as above was tested for tensile strength and elongation. The α-1,3-glucan films produced using a stock solution containing a crosslinking agent exhibited higher tensile strength and elongation properties, as shown in Table 3 below. These characteristics were increased compared to films produced using a stock solution of α-1,3-glucan lacking a crosslinking agent (Table 3).

[0283] Table 3

[0284]

[0285] Example 5

[0286] Film produced using α-glucan stock solution including additives

[0287] The α-1,3-glucan film is produced using a stock solution containing at least one additive.

[0288] A stock solution of α-1,3-glucan containing 15 wt% water-insoluble α-1,3-glucan, 4.9 wt% NaOH and 80.1 wt% water was prepared, followed by the addition of 10 wt% carbon black or bentonite (relative to the weight of α-1,3-glucan in the stock solution). A film was then cast onto a glass surface using a 100 micron doctor blade. The cast film was coagulated using a 5% H2SO4 / 2.5% Na2SO4 aqueous bath and washed with DI water until neutral. The film was then treated in a 5% glycerol aqueous bath and dried.

[0289] The film containing carbon black was black and completely opaque in color, while the film containing bentonite was cloudy white / translucent. The α-1,3-glucan film produced using the stock solution without any additives was clear / transparent.

[0290] Example 6

[0291] Hybrid fibrids produced using alpha-glucan stock solution including additives

[0292] The invention relates to producing α-1,3-glucan fibrids using a stock solution containing at least one additive, and in particular producing fibrids having water-insoluble α-1,3-glucan and a water-soluble cationic ether α-1,3-glucan derivative as additives.

[0293] Stock solutions containing underivatized water-insoluble α-1,3-glucan (DPw about 800, about 100% α-1,3 bonds) and its cationic ether derivative (hydroxypropyltrimethylamine ether derivative, DoS 0.3, water-soluble under non-caustic conditions; i.e., insoluble in water) were prepared. Each stock solution contained 13 wt% of the total glucan content (α-1,3-glucan and its ether derivative) in water and 4.5 wt% NaOH. The ratio of α-1,3-glucan to its ether derivative in the prepared stock solution samples was 100:0 (i.e., no derivative), 95:5, or 80:20 (w / w ratio). The stock solutions were prepared at room temperature (20°C-25°C); after blending the glucan, water, and NaOH, each stock solution was mixed and maintained for 1 hour.

[0294] For fibrid production, each stock solution was fed into a shear mixer simultaneously with 1.5% H2SO4 and mixed (room temperature, tip speed 38m / s, mixing time <1 second). The shear mixer homogenizes the stock solution and the acid solution, resulting in a decrease in the overall pH, thereby precipitating the α-1,3-glucan (now in the form of fibrids). In addition to the glucan fibrids, Na2SO4 salts (from the acid-base reaction) and residual acid were present after mixing. The final mixture had a pH of about 2-3.

[0295] The fibrids were washed in water and analyzed for degree of substitution (DoS) and aspect ratio by NMR (Table 4)

[0296] Table 4

[0297]

[0298] a Weight / weight ratio.

[0299] bHydroxypropyltrimethylamine ether of α-1,3-glucan (DPw about 800, about 100% α-1,3 bonds) with a DoS of 0.03. Insoluble in non-harsh aqueous conditions (such as normal water). na (not applicable).

[0300] c This DoS measurement is an "effective DoS" because the fibrid sample analyzed contained both etherified dextran (DoS 0.3) and underivatized dextran (DoS 0.0).

[0301] The high aspect ratios of the samples measured (Table 4) confirm that the product is in the form of fibrids. NMR confirmed that the fibrids produced using the stock solution having both α-1,3-glucan and its cationic derivatives had DoS measurements, and the fibrids were confirmed to have a positive charge by zeta potential analysis in deionized water (Table 4). Therefore, the fibrids are able to capture charge on and / or within the fibrid structure. This is a noteworthy finding. Since the cationic α-1,3-glucan derivatives used herein are water-soluble, they can potentially remain in solution during the fibrid production process and be washed away. However, even after washing, the charge was found to remain on / within the fibrid particles. It is envisioned that other water-soluble materials can similarly be retained in the solid α-1,3-glucan product herein.

[0302] The method described in this example facilitates the adjustment of charge when producing fibrids and potentially other solid products. By varying the amount of a charged glucan derivative additive in a stock solution with a non-derivatized glucan, the charge on the fibrids and potentially other solids prepared using the stock solution can be adjusted. Now, instead of requiring a specifically charged glucan derivative to be used in the preparation of a specifically charged solid material, the charged glucan derivative additive can simply be blended from its reserve supply into the non-derivatized glucan to achieve the desired charge in the solid product. This blending method also allows for the manufacture of solid products with unique / adjustable charge distributions (depending on how the mixing is performed) compared to using a charged glucan derivative as the only glucan component in the product, which results in a fixed charge distribution in all products manufactured using the charged glucan derivative.

[0303] Example 7

[0304] Film produced using α-glucan stock solution including additives

[0305] The α-1,3-glucan film is produced using a stock solution containing at least one additive.

[0306] This example discloses the use of additives to improve the mechanical properties (e.g., ultimate tensile strength, elongation) of α-1,3-glucan-based materials, such as free-standing films. Small additions of additives—in some cases, less than 0.1 wt% additive relative to the α-1,3-glucan content—increased the ultimate tensile strength to about 140% and the elongation to 77% in free-standing films comprising α-1,3-glucan. Furthermore, by using oil as an additive, it was shown that α-1,3-glucan films with dual hydrophilic and hydrophobic behavior can be produced.

[0307] The following chemicals / compounds were used in this example: α-1,3-glucan (IFF, about 100% α-1,3 bonds, DPw about 800), NaOH (99.5%, ChemSolute), sulfuric acid (95%, ChemSolute), sodium lauryl sulfate (Carlo Erda), BDGE (1,4-butanediol diglycidyl ether, >95%, Sigma Aldrich), polyvinyl alcohol (Kuraray Excel TM AQ-4140, ethylene-modified PVA, hydrolysis degree 98-99 mol%), paraffin wax (Fluka Chemika, product number 76233), rapeseed oil Glycerol (99.5%, Th. Geyer,), sodium sulfate (99%, ChemSolute).

[0308] The caustic stock solution used in this work was prepared by dissolving α-1,3-glucan in an aqueous solution of NaOH (4.2 wt%) at room temperature; the final concentration of α-1,3-glucan in the stock solution was 15 wt%. Additives were added to the formulation. The amounts of additives listed in this example are relative to the amount of α-1,3-glucan in the formulation (and therefore also relative to the amount of α-1,3-glucan in the dried film produced with the caustic stock solution).

[0309] The film was prepared as follows using a caustic stock solution containing α-1,3-glucan and additives. Unless otherwise stated, all work was performed at room temperature. The stock solution was poured onto a glass plate, and a blade coater (ELCOMETER model 3530 / 4) with a gap of about 420 μm was used to cast the film. The glass and cast film were introduced into a coagulation bath filled with an aqueous solution of sulfuric acid (5wt%) and sodium sulfate (2.5wt%) for 5 minutes. During coagulation, the film was detached from the glass plate midway. The film was then immersed in a water bath for 40 minutes. Then, the film was introduced into a bath filled with water and glycerol (5wt%) for 60 minutes. Once the process was completed, the film was dried at room temperature for about 20 hours, with weights applied to the corners to prevent shrinkage. Finally, the film was introduced into an oven at 68°C for 2 hours to obtain a completely dried film. The film has a thickness of about 50 μm.

[0310] The ultimate tensile strength (in megapascals [MPa]) and elongation (percent elongation at break) of the films were measured using the DIN EN ISO 527-3 (incorporated herein by reference) standard procedure. The samples were tested in an AllroundLine Z005 material testing machine with a preload of 0.1 MPa, a test speed of 200 mm / min, and a length of 30.00 mm at the starting position.

[0311] Example 7A

[0312] The crosslinking agent BDGE was used as an additive in the production of α-1,3-glucan films to determine whether it could improve the mechanical properties of the α-1,3-glucan film products. Various amounts of BDGE were added to the α-1,3-glucan stock solution under stirring at room temperature and used to prepare films (according to the above method). The ultimate tensile strength and elongation percentage of each film were measured (Table 5).

[0313] Table 5

[0314]

[0315] An increase of up to about 68% in ultimate tensile strength and about 77% in percent elongation was observed in the α-1,3-glucan films with BDGE additive.

[0316] Example 7B

[0317] PVA was dissolved in water (1 wt%) and a certain amount of this solution was added to a mixture of α-1,3-glucan (15 wt%) in water. NaOH was then added to dissolve the α-1,3-glucan while stirring for 2 hours. Films were prepared from these stock solutions (according to the above method). The ultimate tensile strength and elongation percentage of each film were measured (Table 6).

[0318] Table 6

[0319] PVA relative to dextran (wt%) 0 0.1 0.3 0.5 1.0 Ultimate tensile strength (MPa) 26 51 57 63 50 Elongation(%) 36 26 36 43 41

[0320] An increase of up to about 142% in ultimate tensile strength and about 17% in percent elongation were observed in the α-1,3-glucan films with PVA additive.

[0321] Example 7C

[0322] Paraffin wax was added to a mixture of α-1,3-glucan (15 wt%) and about 0.005 wt% sodium lauryl sulfate in water. NaOH was then added to dissolve the α-1,3-glucan while stirring for 2 hours; the paraffin wax was dispersed in the produced stock solution. Films were prepared from these stock solution emulsions (according to the above method). The ultimate tensile strength and elongation of each film were measured (Table 7).

[0323] Table 7

[0324]

[0325] a Films with 15 wt% and 20 wt% (relative to dextran) paraffin were also prepared.

[0326] An increase of up to about 123% in ultimate tensile strength and about 36% in percent elongation were observed in the α-1,3-glucan films with the paraffin wax additive.

[0327] Furthermore, the optical transparency activity was retained in the α-1,3-glucan films with paraffin additives ( Figure 2 ).

[0328] Example 7D

[0329] Rapeseed oil was added to a mixture of α-1,3-glucan (15 wt%) and about 0.005 wt% sodium lauryl sulfate in water. The amount of rapeseed oil used was for a rapeseed oil having 10 wt%, 15 wt%, or 20 wt%, where the wt% is relative to the α-1,3-glucan content. NaOH was then added to dissolve the α-1,3-glucan while stirring for 2 hours; the rapeseed oil was dispersed in the produced stock solution. Films were prepared from these stock solution emulsions (according to the above method).

[0330] Notably, films containing α-1,3-glucan and rapeseed oil exhibit polarity, with one side being hydrophilic and the other being hydrophobic. In particular, one side of the film formed in direct contact with glass (the "inside") is hydrophilic, while the opposite side (the "outside") is hydrophobic. This hydrophilic / hydrophobic nature can be discerned, for example, by observing that water placed on the inside (hydrophilic) side of the film has a low contact angle with the film, while water placed on the outside (hydrophobic) side of the film easily forms a droplet with a high contact angle with the film. Figure 3 ). This polarity of water-film association was not observed with the α-1,3-glucan films lacking rapeseed oil; water generally beaded up in the same manner on both the inside and outside of the film (data not shown). This hydrophilic / hydrophobic nature of the film surface was not observed with the α-1,3-glucan films with paraffin wax of Example 7C (data not shown).

Claims

1. A composition comprising fibrids comprising water-insoluble α-glucan and an additive, wherein (i) at least about 50% of the glycosidic bonds of the α-glucan are α-1,3 glycosidic bonds, and the α-glucan has a weight average degree of polymerization of at least 15, and (ii) The additive is not chemically linked to the α-glucan.

2. The composition according to claim 1, wherein At least about 90% of the glycosidic bonds of the α-glucan are α-1,3 glycosidic bonds.

3. The composition according to claim 1, wherein The α-glucan has a weight average degree of polymerization of at least 400.

4. The composition according to claim 1, wherein The additive is water soluble under non-harsh conditions.

5. The composition according to claim 1, wherein The additive is water-insoluble under non-harsh conditions.

6. The composition according to claim 1, wherein The fibrids contain at least about 0.5 wt % of the additive and up to about 99.5 wt % of the water-insoluble α-glucan.

7. The composition of claim 1, wherein The additives include charged additives.

8. The composition according to claim 7, wherein The charged additive is a cationic additive.

9. The composition of claim 8, wherein The cationic additive is a cationic polysaccharide derivative.

10. The composition according to claim 9, wherein The polysaccharide of the cationic polysaccharide derivative is α-glucan, At least about 50% of the glycosidic bonds of the α-glucan are α-1,3 glycosidic bonds, and the α-glucan has a weight average degree of polymerization of at least 15.

11. The composition according to claim 9, wherein The cationic polysaccharide derivatives are aqueous soluble under non-harsh conditions.

12. The composition of claim 9, wherein The cationic polysaccharide derivatives include ether-linked cationic organic groups.

13. The composition of claim 12, wherein The ether-linked cationic organic group is a substituted ammonium group.

14. The composition of claim 1, wherein The fibrids are contained in an aqueous medium.

15. The composition of claim 14, wherein The additive is water soluble under non-harsh conditions.

16. The composition of claim 15, wherein At least about 80 wt% of the additive is contained in the fibrids.

17. A method for processing fibrids, the method comprising: (a) providing the fibrid according to claim 1, and (b) contacting the fibrids with a non-caustic aqueous liquid, wherein the contacting does not remove any of the additive from the fibrids, or the contacting removes less than 20 wt% of the additive from the fibrids.

18. The method of claim 17, further comprising separating the non-caustic aqueous liquid from the fibrids, wherein the non-caustic aqueous liquid does not contain any of the additive, or the non-caustic aqueous liquid contains less than 20 wt % of the additive in the fibrids prior to the contacting step (b).

19. The method of claim 17, wherein: The additive is water soluble under non-harsh conditions.

20. The method of claim 17, wherein: The additives include charged additives.